US10806511B1 - Partially insulated focused radiofrequency ablation catheter - Google Patents
Partially insulated focused radiofrequency ablation catheter Download PDFInfo
- Publication number
- US10806511B1 US10806511B1 US14/942,442 US201514942442A US10806511B1 US 10806511 B1 US10806511 B1 US 10806511B1 US 201514942442 A US201514942442 A US 201514942442A US 10806511 B1 US10806511 B1 US 10806511B1
- Authority
- US
- United States
- Prior art keywords
- ablation
- catheter
- insulating layer
- tip
- pifa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 238000007674 radiofrequency ablation Methods 0.000 title claims abstract description 39
- 238000002679 ablation Methods 0.000 claims abstract description 264
- 238000000576 coating method Methods 0.000 claims abstract description 31
- 239000011248 coating agent Substances 0.000 claims abstract description 28
- 229910052582 BN Inorganic materials 0.000 claims abstract description 23
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 claims abstract description 23
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 23
- 229920002554 vinyl polymer Polymers 0.000 claims abstract description 19
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims abstract description 16
- 239000002131 composite material Substances 0.000 claims abstract description 13
- 229920002635 polyurethane Polymers 0.000 claims abstract description 12
- 239000004814 polyurethane Substances 0.000 claims abstract description 12
- 230000002262 irrigation Effects 0.000 claims description 18
- 238000003973 irrigation Methods 0.000 claims description 18
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 16
- 239000004593 Epoxy Substances 0.000 claims description 15
- 239000010432 diamond Substances 0.000 claims description 14
- 229910003460 diamond Inorganic materials 0.000 claims description 14
- 238000010292 electrical insulation Methods 0.000 claims description 12
- 229910002804 graphite Inorganic materials 0.000 claims description 9
- 239000010439 graphite Substances 0.000 claims description 9
- 239000002041 carbon nanotube Substances 0.000 claims description 7
- 229910021393 carbon nanotube Inorganic materials 0.000 claims description 7
- 230000000295 complement effect Effects 0.000 claims description 2
- 230000004075 alteration Effects 0.000 claims 1
- 230000003902 lesion Effects 0.000 abstract description 94
- 238000009413 insulation Methods 0.000 abstract description 61
- 238000010438 heat treatment Methods 0.000 abstract description 20
- 230000036961 partial effect Effects 0.000 abstract description 17
- 238000001727 in vivo Methods 0.000 abstract description 13
- 239000004020 conductor Substances 0.000 abstract description 6
- 239000012774 insulation material Substances 0.000 abstract description 4
- 210000001519 tissue Anatomy 0.000 description 57
- 230000002107 myocardial effect Effects 0.000 description 23
- 210000003105 phrenic nerve Anatomy 0.000 description 22
- 230000006378 damage Effects 0.000 description 17
- 238000013461 design Methods 0.000 description 16
- 239000006185 dispersion Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 206010003119 arrhythmia Diseases 0.000 description 15
- 229910052751 metal Inorganic materials 0.000 description 15
- 239000002184 metal Substances 0.000 description 15
- 210000004165 myocardium Anatomy 0.000 description 15
- 230000003247 decreasing effect Effects 0.000 description 14
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 208000014674 injury Diseases 0.000 description 13
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 12
- 230000006793 arrhythmia Effects 0.000 description 12
- 210000001992 atrioventricular node Anatomy 0.000 description 12
- 210000005003 heart tissue Anatomy 0.000 description 10
- 238000013022 venting Methods 0.000 description 10
- 206010003671 Atrioventricular Block Diseases 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- 238000013153 catheter ablation Methods 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 208000010271 Heart Block Diseases 0.000 description 7
- 210000003516 pericardium Anatomy 0.000 description 7
- 238000013507 mapping Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 241000282887 Suidae Species 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 210000003540 papillary muscle Anatomy 0.000 description 5
- 206010003658 Atrial Fibrillation Diseases 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004375 bundle of his Anatomy 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000011810 insulating material Substances 0.000 description 3
- 208000037816 tissue injury Diseases 0.000 description 3
- 206010047302 ventricular tachycardia Diseases 0.000 description 3
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 241001553178 Arachis glabrata Species 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 229920001651 Cyanoacrylate Polymers 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 2
- 208000003734 Supraventricular Tachycardia Diseases 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009529 body temperature measurement Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 210000003748 coronary sinus Anatomy 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 229960004194 lidocaine Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 208000008494 pericarditis Diseases 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 239000000565 sealant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000000591 tricuspid valve Anatomy 0.000 description 2
- 210000002620 vena cava superior Anatomy 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010003662 Atrial flutter Diseases 0.000 description 1
- 208000006808 Atrioventricular Nodal Reentry Tachycardia Diseases 0.000 description 1
- 206010003673 Atrioventricular block complete Diseases 0.000 description 1
- 229910001020 Au alloy Inorganic materials 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910001260 Pt alloy Inorganic materials 0.000 description 1
- 235000013290 Sagittaria latifolia Nutrition 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- IYIKLHRQXLHMJQ-UHFFFAOYSA-N amiodarone Chemical compound CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1 IYIKLHRQXLHMJQ-UHFFFAOYSA-N 0.000 description 1
- 229960005260 amiodarone Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 235000015246 common arrowhead Nutrition 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000010616 electrical installation Methods 0.000 description 1
- 210000001174 endocardium Anatomy 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 238000002847 impedance measurement Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 201000002931 third-degree atrioventricular block Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
- A61B2018/00029—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00071—Electrical conductivity
- A61B2018/00083—Electrical conductivity low, i.e. electrically insulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00089—Thermal conductivity
- A61B2018/00095—Thermal conductivity high, i.e. heat conducting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
- A61B2018/00119—Coatings on the energy applicator with metal oxide nitride
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
- A61B2018/00136—Coatings on the energy applicator with polymer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00714—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00744—Fluid flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2217/00—General characteristics of surgical instruments
- A61B2217/002—Auxiliary appliance
- A61B2217/007—Auxiliary appliance with irrigation system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
- A61B2218/002—Irrigation
Definitions
- This invention relates to medical devices. More specifically, this invention relates to partially insulated radiofrequency ablation catheter tips.
- Cardiac arrhythmias comprise a major health problem; ventricular arrhythmias are the number one cause of death in the U.S. Cardiac ablation using radiofrequency (RF) energy is the standard treatment for most arrhythmias refractory to medical therapy.
- RF current heats tissue via resistive heating of a thin rim of tissue that is in direct contact with the ablation tip [Nath S, et al., J Cardiovasc Electrophysiol. 1994; 5:863-876]. Deeper tissue heating is due to passive thermal conduction from this small area of volume heating, [Haines D. J Cardiovasc Electrophysiol.
- ablation lesion size is related to the temperature at the electrode-tissue interface, size of the ablation tip, RF duration, and tissue contact [Langberg J J, et al., Pacing Clin Electrophysiol. 1990; 13:1242-1248; Otomo K, et al., J Cardiovasc Electrophysiol. 1998; 9:47-54; Haines D E, et al., Circulation. 1990; 82:1034-1038].
- RF ablation is the inability to achieve durable lesions with the safe delivery of low power to myocardial tissue.
- ablation may be constrained due to anatomic considerations, such as proximity to critical structures, including the atrioventricular (AV) node, phrenic nerve, or pericardium [Hintringer F, et al., Circulation. 1995; 92:3490-3496; Yong Ji S, et al., J Cardiovasc Electrophysiol. 2013; Killu A M, et al., Heart Rhythm. 2013; 10:1613-1621].
- AV atrioventricular
- phrenic nerve or pericardium
- Radiofrequency (RF) ablation has revolutionized the treatment of cardiac arrhythmias over the last couple decades.
- significant limitations remain, in terms of both safety and efficacy of RF ablation. Risks include collateral damage to vital cardiac and non-cardiac structures and unnecessary ablation of healthy tissue.
- durable and effective ablation lesions can be incomplete, particularly for challenging arrhythmias, such as atrial fibrillation and ventricular tachycardia.
- Radiofrequency ablation catheters have radial symmetry at the catheter tip cylinder allowing for the delivery of RF at all sites of the catheter.
- RF energy applied in an unrestricted manner from the circumferential catheter tip cylinder results in complications due to unintended collateral injury to structures adjacent to the targeted cardiac tissue. This situation is most commonly observed during RF application near the atrioventricular node and in the epicardium. When energy is applied to tissue below the AV node, RF energy is inevitably delivered higher than what is targeted.
- catheters used for the delivery of RF energy on the epicardium deliver the energy circumferentially through a metal tip. This inefficient method results in the unnecessary heating and ablation of the pericardium and often results in pericarditis (a common complication of the procedure).
- An insulated catheter where RF energy is concentrated to a single side, will allow for a more effective ablation at lower powers, potentially improving safety. It will also permit RF delivery deeper into tissues and is therefore useful for difficult arrhythmias arising from deep structures such as the septum, papillary muscle, and cavo-tricuspid isthmus.
- the present invention provides an ablation catheter system for ablating the tissue of a body, such as cardiac tissue.
- the ablation catheter system includes a catheter body including a distal tip, at least one ablation electrode at the distal tip of the catheter body and an insulating layer disposed over a portion of the ablation electrode, wherein the insulating layer prevents or reduces the application of heat to tissues adjacent to the site of ablation.
- the distal tip of the ablation catheter can be rotatable. By making the tip and/or insulation rotatable a user can alter the orientation of the insulating layer.
- the insulating layer of the first aspect can be a thermally conductive electrical insulation.
- the insulating layer can be aluminum oxide, boron nitride, aluminum oxide and boron nitride composite, silicone, vinyl, polyurethane, carbon nanotubes oriented perpendicular to the RF current, graphite embedded in thermal epoxy or diamond embedded in thermal epoxy.
- the insulating layer is an aluminum oxide/boron nitride (AOBN) coating.
- AOBN aluminum oxide/boron nitride
- the insulating layer is applied to about one-half of the surface area of the tip.
- the tip of the ablation catheter system can be a non-irrigated about 4 mm RF catheter tip, non-irrigated 8 mm RF catheter tip, and an open-irrigated RF ablation catheter tip.
- the insulating layer covers the superior aspect of the catheter tip. In other words, the aspect of the tip away from the site of ablation is covered with insulating material. In another embodiment the insulating layer covers about one-half of the catheter tip.
- the ablation catheter system can include one or more ports in the insulation to allow for irrigation through the insulating layer.
- the ablation catheter system can employ an insulating layer that has a plurality of holes dispersed over the insulating layer thereby exposing portions of the metal ablation tip through the holes in the insulating. This allows for venting from the metal underneath the insulation.
- the present invention provides a second ablation catheter system for ablating the tissue of a body.
- the ablation catheter system of the second aspect includes a catheter body including a distal tip, at least one ablation electrode at the distal tip of the catheter body, and an insulating layer disposed over a portion of the ablation electrode.
- the insulating layer has a plurality of holes dispersed over the insulating layer to expose portions of the metal ablation tip through the holes in the insulating layer. The insulating layer prevents or reduces the application of heat to tissues adjacent to the site of ablation.
- the insulating layer of the first aspect can be a thermally conductive electrical insulation.
- the insulating layer can be aluminum oxide, boron nitride, aluminum oxide and boron nitride composite, silicone, vinyl, polyurethane, carbon nanotubes oriented perpendicular to the RF current, graphite embedded in thermal epoxy or diamond embedded in thermal epoxy.
- the insulating layer is an aluminum oxide/boron nitride (AOBN) coating.
- AOBN aluminum oxide/boron nitride
- the insulating layer is applied to about one-half of the surface area of the tip.
- the tip of the ablation catheter system can be a non-irrigated about 4 mm RF catheter tip, non-irrigated 8 mm RF catheter tip, and an open-irrigated RF ablation catheter tip.
- the insulating layer covers the superior aspect of the catheter tip. In other words, the aspect of the tip away from the site of ablation is covered with insulating material. In another embodiment the insulating layer covers about one-half of the catheter tip.
- the ablation catheter system can include one or more ports in the insulation to allow for irrigation through the insulating layer.
- the present invention provides an interchangeable ablation catheter tip for a radiofrequency ablation catheter.
- the interchangeable ablation catheter tip includes an ablation electrode which has an insulating layer disposed over a portion of the ablation electrode. The insulating layer prevents or reduces the application of heat to tissues adjacent to the site of ablation.
- the interchangeable ablation catheter tip is adapted to releasably engage a distal tip of a radiofrequency catheter body, thus facilitating the exchange of catheter tips on a catheter.
- the tip can be a non-irrigated about 4 mm RF catheter tip, a non-irrigated 8 mm RF catheter tip, or an open-irrigated RF ablation catheter tip.
- the insulating layer covers the superior aspect of the catheter tip.
- the aspect of the tip away from the site of ablation is covered with insulating material.
- the insulating layer covers about one-half of the catheter tip.
- the interchangeable ablation catheter tip can include one or more ports in the insulation to allow for irrigation through the insulating layer.
- the interchangeable ablation catheter tip can employ an insulating layer that has a plurality of holes dispersed over the insulating layer thereby exposing portions of the metal ablation tip through the holes in the insulating. This allows for venting from the metal underneath the insulation.
- the insulating layer of the interchangeable ablation catheter tip can be a thermally conductive electrical insulation.
- the insulating layer can be aluminum oxide, boron nitride, aluminum oxide and boron nitride composite, silicone, vinyl, polyurethane, carbon nanotubes oriented perpendicular to the RF current, graphite embedded in thermal epoxy or diamond embedded in thermal epoxy.
- the insulating layer is an aluminum oxide/boron nitride (AOBN) coating.
- FIG. 1 is a set of three images illustrating partially insulated, focused ablation (“PIFA”) catheter and thermocouple positions for depth temperature measurements.
- PIFA partially insulated, focused ablation
- A shows the non-insulated side of the PIFA catheter is parallel to the myocardium. Thermocouple wires are inserted beneath the catheter tip-myocardium interface at depths of 3 and 5 mm.
- B shows shows the thermochromic pattern created with a standard catheter on heat sensitive liquid crystal paper.
- C shows the thermochromic pattern created with the PIFA catheter on heat sensitive liquid crystal paper.
- PIFA partially insulated, focused ablation.
- FIG. 2 is an image illustrating PIFA catheter and thermocouple positions for surface temperature measurements. Thermocouple wire tips are placed on the myocardial surface on either side of the PIFA catheter at 1, 2, and 4 mm distance from the catheter.
- FIG. 3A is a graph illustrating the mean temperature dispersion at 3 and 5 mm depths for 20 W beneath the non-insulated side of a 4 mm PIFA catheter vs. a 4 mm standard (STD) catheter.
- the upper solid line is the PIFA 3 mm catheter, while the lower solid line (with arrowhead) is the PIFA 5 mm.
- the upper dotted line is the STD 3 mm, while the lower dashed line is the STD 5 mm.
- FIG. 3B is a graph illustrating the mean temperature dispersion at 3 and 5 mm depths beneath the non-insulated side of an 8 mm PIFA catheter-ablated myocardium compared to a standard 8 mm ablation catheter.
- the upper solid line is the PIFA at 3 mm, while the line immediately below is the PIFA catheter at 5 mm.
- the dotted line is the STD at 3 mm, while the lower dashed line is the STD at 5 mm.
- FIG. 3C is a graph illustrating the mean temperature dispersion at 3 and 5 mm depths beneath the non-insulated side of an open irrigated PIFA catheter-ablated myocardium compared to a standard open irrigated ablation catheter.
- the upper solid line is the PIFA at 3 mm
- the dotted line is the PIFA at 5 mm.
- the upper dotted line is the STD at 3 mm
- the lower dashed line is the STD at 5 mm.
- FIG. 4A is a graph illustrating the mean surface temperature dispersion at 1 mm, 2 mm, and 4 mm distances from each side (insulated, non-insulated) of a 4 mm PIFA catheter.
- the upper thick black solid line with the arrow head is the plot of the 1 mm to the non-insulated side of the PIFA catheter.
- the next line, the middle dashed black line is the plot of the 2 mm non-insulated side of the PIFA catheter.
- the upper, roughly coextensive black dotted line is the 1 mm insulated side of the PIFA catheter and the 2 mm insulated side of the PIFA catheter (i.e.
- the thinner solid black line where the 1 mm catheter has a slightly higher temperature at 20 seconds and slightly lower temperature at 70 seconds.
- the lowest line(s) plotted in FIG. 4A represent the 4 mm non-insulated side of the PIFA catheter and 4 mm insulated side of the PIFA catheter. The plots are co-extensive and difficult to distinguish in gray scale.
- FIG. 4B is a graph illustrating the mean surface temperature dispersion at 1 mm, 2 mm, and 4 mm distances from each side (insulated, non-insulated) of a standard 4 mm catheter.
- the upper line plot represents both the 1 mm superior to the standard catheter and 1 mm inferior to the standard catheter.
- the middle line plot represents 2 mm superior to the standard catheter and 2 mm inferior to the standard catheter.
- the lower line plot represents 4 mm superior to the standard catheter and 4 mm inferior to the standard catheter.
- FIG. 4C provides comparisons between the catheters as shown in FIGS. 4A and 4B .
- FIG. 5A is a graph illustrating the change in impedance (mean starting and ending impedance) measurements in myocardial tissue before and after ablation at 20 Watts using a 4 mm PIFA catheter and an open irrigated PIFA catheter.
- the 4 mm PIFA and open irrigated PIFA catheter-ablated myocardial tissues had higher starting and ending impedances with a larger impedance reductions observed with ablation. This was similar for the 8 mm PIFA catheter results at both 30 Watts and 60 Watts ( FIG. 5B ).
- FIG. 5B is a graph illustrating the change in impedance (mean starting and ending impedance) measurements in myocardial tissue for the 8 mm PIFA catheter results at both 30 Watts and 60 Watts.
- FIG. 6 is a pair of images illustrating in vivo epicardial ablation using open irrigated standard catheter (A) and PIFA open irrigated catheter (B).
- A the control epicardial lesion (open arrow) is adjacent to pericardium (black arrow) that appears ablated.
- B the PIFA lesion (open arrow), although significantly larger than the control lesion, is adjacent to normal appearing pericardium (black arrow).
- FIG. 7A is a graph illustrating the mean surface temperature dispersion at 1 mm, 2 mm, and 4 mm distances from each side (insulated, non-insulated) of an open irrigated PIFA catheter.
- FIG. 7A Mean Surface Temperature Dispersion at 1 mm, 2 mm, and 4 mm Distances From Each Side (insulated, non-insulated) of a 8 mm PIFA Catheter.
- FIG. 7B is a graph illustrating the mean surface temperature dispersion at 1 mm, 2 mm, and 4 mm distances from each side (insulated, non-insulated) of a standard open irrigated catheter.
- FIG. 7B Mean Surface Temperature Dispersion at 1 mm, 2 mm, and 4 mm Distances From Each Side of a Standard 8 mm Catheter.
- upper line 4 mm inferior to the standard catheter
- third line 2 mm inferior to the standard catheter
- fourth line 2 mm superior to the standard catheter
- lower line 2 mm superior to the standard catheter.
- FIG. 7C provides comparisons between the catheters as shown in FIGS. 7A and 7B .
- FIG. 7C Combined Mean Surface Temperature Dispersion at 1 mm, 2 mm, and 4 mm Distances From Each Side (insulated, non-insulated) of a 8 mm PIFA Catheter and Standard (STD) 8 mm Catheter.
- FIG. 8A is a graph illustrating the mean surface temperature dispersion at 1 mm, 2 mm, and 4 mm distances from each side (insulated, non-insulated) of a 8 mm PIFA catheter.
- FIG. 8B is a graph illustrating the mean surface temperature dispersion at 1 mm, 2 mm, and 4 mm distances from each side (insulated, non-insulated) of a standard 8 mm catheter.
- FIG. 8C provides comparisons between the catheters shown in FIGS. 7A and 7B .
- FIG. 9 is a pair of photographs illustrating the ablation lesions at 40 W for a normal catheter (A) and an insulated catheter (B).
- FIG. 10 is a graph illustrating the temperatures for the PIFA “hooded” catheter compared to a standard “normal” catheter.
- FIG. 11 is a pair of images illustrating RF heating from a “normal” catheter (above) and an insulated catheter (below) wherein the insulated catheter has a layer of insulation on the upper aspect of the catheter tip.
- FIG. 12 is an illustration of the tip exchange for a single catheter modification.
- FIG. 13 is an illustration of an electrically active threaded stump catheter shaft and the complementary portion of an exchangeable catheter tip that the shaft interfaces with.
- FIG. 14 is an illustration of the catheter tip interface for a standard 4 mm catheter tip.
- FIG. 15 is an illustration of the catheter tip interface for a solid tip partially insulated 4 mm catheter tip.
- FIG. 16 is an illustration of the catheter tip interface for a solid tip partially insulated 4 mm—SN4 AVNRT catheter tip.
- FIG. 17 is an illustration of the catheter tip interface for a “thimble” partially insulated open irrigated 3.5 mm catheter tip.
- FIG. 18 is an illustration of the catheter tip interface for a standard solid 8 mm catheter tip.
- FIG. 19 is an illustration of the catheter tip interface for a standard solid 8 mm—effectively cooled 4 mm catheter tip.
- FIG. 20 is an illustration of the catheter tip interface for a standard solid 8 mm—effectively cooled and insulated 4 mm catheter tip.
- FIG. 21 is an illustration of the catheter shaft designed to accept specialized disposable tubing for irrigation.
- FIG. 22 is an illustration of a solid tip partially insulated and with external irrigation tubing design.
- FIG. 23 is an illustration of a radiofrequency venting catheter design showing the vents in the insulation covering a portion of the tip of the catheter.
- FIG. 24 is an illustration of the vents in the insulation of a radiofrequency venting catheter.
- FIG. 25 is a graph illustrating the mean temperature dispersion at 3 and 5 mm depths for 20 Watts using irrigated Arctic Alumina insulation, irrigated Arctic Alumina vented insulation, and control open irrigated ablation.
- FIG. 26 is an image depicting ablation of AVNRT.
- AVNRT ablation of AVNRT
- targeting of the slow pathway is in the triangle between the tricuspid valve and the coronary sinus, but the superior side of a standard ablation catheter applies unnecessary and unsafe RF towards the AV node.
- the insulated superior aspect of the PIFA mitigates this collateral damage to the AV node.
- FIG. 27 is a pair of images depicting in vivo porcine ablations. During in vivo porcine ablations, ablation was performed very close to the His cloud, as demonstrated by the dark ablation lesion tags next to the light His tags. His—Bundle of His. RA—right atrium. LAO—Left anterior oblique. RAO—Right anterior oblique.
- FIG. 28A is a graph illustrating ablation near the His region. Ablation near the His region with an open irrigated PIFA catheter did not result in heart block, compared to heart block occurring in all controls. FIG. 28A shows an open irrigated PIFA catheter.
- FIG. 28B is a graph illustrating ablation near the His region. Ablation near the His region with an open irrigated PIFA catheter did not result in heart block, compared to heart block occurring in all controls. FIG. 28B shows an open irrigated control.
- FIG. 28C is a bar graph comparing the heart block between the open irrigated PIFA catheter and the open irrigated control.
- FIG. 29 is a pair of images depicting PIFA ablations.
- PIFA ablations as denoted by light tags, are alternated with control ablations, denoted by dark lesion tags, for both endocardial and epicardial ablation near the right and left phrenic nerves.
- FIG. 30 is a pair of graphs illustrating that in both epicardial and endocardial ablations, PIFA caused fewer loss of phrenic nerve capture compared to controls.
- Partially insulated focused ablation (PIFA) catheters using thermally conductive materials have differential radiofrequency (RF) heating and thereby allow for tailored RF application.
- PIFA catheters can minimize risk of injury to critical structures, such as the phrenic nerve and AV node, during ablation.
- Open-irrigated, 4 mm, and 8 mm RF ablation catheters were partially insulated by coating half their surfaces with a layer of vinyl, silicone, vinyl-silicone, polyurethane, or a composite of aluminum oxide/boron nitride (AOBN).
- AOBN aluminum oxide/boron nitride
- Effective radiofrequency ablation can be impacted by the size of the ablation catheter tip, temperature at the electrode-tissue interface, RF duration, and tissue contact.
- a partially insulated catheter tip is disclosed and shown to impact ablation lesion size and shape, thereby providing additional tools to tailor the ablation to the user's needs.
- the insulation alters RF lesion geometry with minimal effect on tip temperatures.
- Existing catheters were modified by coating a portion of the metallic tip using a thin layer of insulation that also is thermally conductive. This allows for a more tailored cardiac ablation by improving heating under the non-insulated side of the catheter while decreasing undesired RF-mediated injury from the insulated side.
- Insulation materials were investigated to demonstrate their effect on asymmetrical lesion formation while protecting the tissue adjacent to the insulated aspect of the ablation catheter tip. Using these insulation materials, we performed in vivo ablation near critical structures to demonstrate the ability of PIFA to protect these structures.
- RF energy is routinely performed for the treatment of a variety of arrhythmias. All radiofrequency ablation catheters are radially symmetric at the catheter tip cylinder, thus allowing for circumferential RF.
- catheter design allows for a more tailored approach during RF ablation in which circumferential ablation is not desired.
- RF energy restricted to a single side of the catheter may prevent complications due to unintended collateral injury to vital structures adjacent to the targeted cardiac tissue. This situation is most commonly observed during RF application near the AV node, in the epicardium, and near the phrenic nerve.
- a circumferential catheter tip may lead to unintended loss of RF to surrounding blood flow, thus decreasing the efficacy of ablation.
- An insulated catheter, where RF energy is concentrated to a single side, will allow for a more effective ablation at lower powers, potentially improving safety. It will also permit RF delivery deeper into tissues and is therefore useful for difficult arrhythmias arising from deep structures such as the septum, papillary muscle, and cavo-tricuspid isthmus.
- An insulated catheter has been designed and engineered, using a silicone-vinyl coating on half the surface of a catheter tip to direct RF energy preferentially and asymmetrically to the non-insulated side of the catheter tip.
- Ablation studies with these PIFA catheters have met two principal objectives for clinical applicability. First, it is shown herein that the insulated sides of the PIFA catheters have decreased temperature changes and minimal tissue injury when RF ablation is delivered. Secondly, it is shown that the non-insulated sides of these catheters deliver a greater degree of tissue heating with less power, which results in larger ablation lesions.
- FIGS. 12, 15-20 and 23-24 show exemplary coating patterns.
- a plurality of different coating patterns ( 20 ) are disclosed.
- Cather tips 20 a and 20 d have a coating over roughly one-half of the surface of the tip, with the coating applied to superior side of the tip, or the surface area that would be away from the tissue being ablated. Other coating patterns are possible.
- catheter tip 20 b has additional insulation completely covering the distal portion of the catheter tip, while catheter tips 20 c and 20 e have the distal portion of the catheter tip exposed.
- catheter tip 20 a shows roughly 50% of the tip covered with insulation, it is contemplated that roughly 25%, 30%, 40%, 50%, 60%, 70% or 75% of the tip could be covered by insulation depending upon the application and needs of the user.
- FIG. 17 shows a partially insulated open irrigated 3.5 mm catheter tip having a thin layer of insulation 22 coating the metal surface 21 (having holes 23 ) of the catheter 20 .
- FIG. 23 shows an ablation catheter 10 with a catheter tip 20 having a thin layer of insulation 22 over the metal 21 of the catheter tip 20 .
- the thin layer of insulation 22 has a plurality of holes 22 a through the insulation to allow for venting from the metal 21 .
- the vents 22 a are shown in more detail in FIG. 24 .
- suitable coating materials include aluminum oxide, boron nitride, aluminum oxide and boron nitride composite, silicone, vinyl, polyurethane, carbon nanotubes placed perpendicular to RF current, graphite embedded in thermal epoxy and diamond embedded in thermal epoxy. These coatings would be over a tip constructed of a material such as Gold, Platinum, and Platinum-Iridium and gold and platinum alloys. The modification of the coating allows for a more tailored cardiac ablation by improving heating under the non-insulated side of the catheter while decreasing undesired RF-mediated injury from the insulated side.
- PIFA catheters Partially insulated, focused ablation (PIFA) catheters were created whereby one side of various ablation catheter tips (4 mm, 8 mm, and open irrigated) was insulated with a very thin layer of thermal adhesive coating to eliminate RF conductivity on this side, while also allowing for convective cooling of the catheter tip to prevent tip temperature limitations.
- PIFA focused ablation
- a catheter has also been developed that can be easily converted from the current radially symmetric catheter tip into an insulated tip.
- This catheter design allows operators to exchange or convert from the current radial tip technology to a partially insulated tip. Exemplary exchangeable tips are shown in FIGS. 12, 15-17, 19-20 and 23-24 .
- the design which can include a rotating insulated cover, allows for either side of the catheter to be insulated, thereby maintaining the bi-directionality of the catheter.
- This catheter will allow clinicians to tailor their ablation strategy according to the type of cardiac tissue being targeted and depending on the arrhythmia of interest.
- This technology was developed using the standard 4 mm ablation catheter, but the design can easily be accommodated to the 8 mm catheter and the irrigated tip catheter.
- the insulated cover is in a fixed orientation with respect to the catheter tip, but further embodiments include a rotating insulated cap around the ablation catheter tip.
- a rotating insulated cap around the ablation catheter tip allows the use of all sides of the ablation catheter, with the operators tailoring their partial insulation in the direction that they prefer.
- This partially insulated, rotating cap can be applied to the standard 4 mm catheter, as well as the 8 mm catheter and an irrigated tip catheter.
- FIGS. 21 and 22 disclose examples of tips with external irrigation tubing.
- tip designs proposed herein can be applied to the following tip types: peanut, tapered, deformable “Blob” tip, CNT coated tip, gold or copper tip, needle tip and proximally coated 10 mm tip (electrical insulation with high thermal conductivity).
- Tailored and facilitated RF ablation is paramount and is an unmet need in ablation technology.
- Different areas of the heart have diverse physical properties and react differently to ablation.
- RF ablation catheters all have the same design, with their inherent limitations, and one catheter tip design is not meant to treat all different types of tissue or arrhythmia.
- the only “tailoring” that can be currently performed with these catheters is to manually orient them differently or to titrate the amount of energy being delivered.
- the development of an insulated cover will allow for another dimension of tailoring, making ablation safer, while at the same time more effective.
- This technology has the potential for altering the practice of an entire field of therapeutics with a large demand of services in a high volume of patients.
- This catheter could be considered for any catheter ablation procedure where focused ablation and/or tailored protective insulation are preferred.
- the arrhythmias that may be treated using this catheter include atrial flutter, AV nodal reentrant tachycardia, supraventricular tachycardia, atrial fibrillation, and ventricular tachycardia.
- a non-irrigated 4 mm RF catheter, non-irrigated 8 mm RF catheter, and an open-irrigated RF ablation catheter were partially insulated by coating half their surfaces with a thin layer of thermally conductive material, including either a layer of vinyl, silicone, vinyl-silicone, polyurethane, or a composite of aluminum oxide/boron nitride (AOBN) (See e.g. FIGS. 12, 15-20 and 23 ).
- the coatings were created with an epoxy allowed to dry, leaving a thin ( ⁇ 0.1 mm) layer covering half of the metallic tip.
- AOBN a very effective insulation coating
- a series of ablation lesions with each catheter was created on the recently excised bovine myocardium, with the insulated or non-insulated side parallel to the myocardium.
- a separate set of lesions was created using temperature control mode for maximum power (50 Watts for 4 mm and irrigated tip and 70 W for 8 mm), with tip temperature limits set at ⁇ 55° C. (4 mm), ⁇ 60° C. (8 mm) and ⁇ 45° C. (irrigated tip), for 60-second ablations.
- the number of lesions applied per ventricular section depended upon the available endocardial surface. No lesions were placed over or in immediate proximity of papillary muscles (5 mm) or within immediate proximity of other lesions. Furthermore, no lesions were placed within 1 cm of section edge.
- Ablations were delivered at 50 W for 30 seconds with the same amount of force as measured by SmartTouch technology on the RF catheters (Biosense-Webster, Diamond Bar, Calif.); ablation lesions were tagged by the electroanatomic mapping system. Ablations with both PIFA and standard catheters were performed in the same epicardial region. Saline irrigant was suctioned from the epicardium after each ablation. Following ablation, animals were sacrificed and the hearts and their pericardium were immediately explanted and fixed in formalin. Gross pathology was performed; pericardial tissue were assessed for injury, and epicardial ablation lesions were analyzed.
- a decapolar catheter was used to pace and capture the right and left phrenic nerves, either in the endocardium or epicardium.
- a force-sensing PIFA irrigated tip catheter and a standard force-sensing irrigated tip catheter were used to deliver alternating PIFA and standard irrigated “control” ablation lesions directly below the site of phrenic nerve capture. After each ablation, pacing and capture of the phrenic nerve was moved inferiorly. Loss of phrenic nerve capture, time to loss of phrenic nerve capture, and time to phrenic nerve recovery (as established by return of phrenic nerve capture) were recorded and compared for PIFA and control.
- the insulated aspect of the catheter tip was superiorly oriented toward the phrenic nerve.
- Ablations were delivered at 50 W for 30 seconds with the same amount of force as measured by SmartTouch technology on the RF catheters (Biosense-Webster, Diamond Bar, Calif.); ablation lesions were tagged by the electroanatomic mapping system. Saline irrigant was suctioned from the epicardium after each ablation.
- the Bundle of His was mapped on the septal tricuspid annulus. Once the His region was annotated, either a standard irrigated catheter or a PIFA catheter was placed directly below the His and ablation was performed. AV block, time to AV block, and recovery of conduction after immediate cessation of ablation, if any, were recorded. During PIFA ablation, the insulated aspect of the catheter tip was superiorly oriented toward the His. Ablations were delivered at 50 W for 30 seconds with the same amount of force as measured by SmartTouch technology on the RF catheters (Biosense-Webster, Diamond Bar, Calif.); ablation lesions were tagged by the electroanatomic mapping system.
- Lesion volumes were acquired by analyzing tissue sections with a digital micrometer.
- LesionVolume [ 1.33 ⁇ ⁇ ⁇ ( D ) ⁇ ( W 2 ) ⁇ ( L 2 ) ] / 2
- Lesion volumes were acquired by analyzing tissue sections with a digital micrometer. Single lesion volumes were calculated using the equation for an oblate ellipsoid. For each lesion, maximum depth (A), maximum diameter (B), depth at maximum diameter (C), and lesion surface diameter (D) were measured.
- LesionVolume ⁇ [ 0 . 7 ⁇ 5 ⁇ ⁇ ⁇ ( B 2 ) 2 ⁇ ( A - C ) ] - [ 0 . 2 ⁇ 5 ⁇ ⁇ ⁇ ( D 2 ) 2 ⁇ ( A - 2 ⁇ C ) ]
- Equation 2 volume of oblate ellipsoid
- A maximum depth
- B maximum diameter
- C depth at maximum diameter
- D lesion surface diameter
- T-type thermocouple wires were inserted horizontally into myocardium at 3 mm and 5 mm depths and beneath the ablation surface during ablations with the standard catheter or non-insulated aspect of the PIFA catheter parallel to the myocardium ( FIGS. 1 and 2 ). Furthermore, T-type thermocouple wires were placed horizontally into myocardium at 1 mm, 2 mm, and 4 mm distances from each side of the ablation catheter, with the ablation catheter oriented as shown in FIG. 2 in relationship to the myocardium. Thermocouple analogue inputs were converted to digital signals using LabView software (version 7.0). Temperatures were recorded in a continuous fashion throughout the 60 seconds of RF application at a rate of 5 Hertz.
- Peak tissue temperature was defined as the maximum temperature reading during RF application.
- Initial temperature rise rate was defined as the amount of temperature rise in the first 30 seconds and area under curve (AUC) corresponded to total temperature change over total RF time (60 seconds). RF applications that generated steam pops were excluded from temperature curve analysis.
- SPSS software was used to perform all calculations.
- the Analysis of Variance (ANOVA) test was used to compare continuous variables and the Chi-square test was used for dichotomous comparisons in lesion characteristics from PIFA catheter-ablated myocardium vs. lesions ablated by corresponding non-insulated catheters.
- This effect was similar for the 8 mm PIFA catheter, compared to a standard 8 mm catheter, at varying powers from 30 W to 60 W (the standard 8 mm catheter created negligible lesions at 20 W, and these were unable to be used for comparisons to the 8 mm PIFA lesions at 20 W).
- the same phenomenon was observed for the open irrigated catheter at 20 W, with the PIFA irrigated catheter creating volumes of 75.4 mm 3 , compared to 22.1 mm 3 (p ⁇ 0.001) for the standard open irrigated catheter.
- Ablation lesions could not be created on tissue exposed to the insulated side of each PIFA catheter.
- Tables 1 and 2 show the differences in ablation lesion shape and size, depending on the catheter used.
- the tip temperatures for all ablation lesions created with all catheters tested were ⁇ 55° C. (4 mm and 8 mm) and ⁇ 45° C. (irrigated tip) at the fixed powers tested.
- Temperature control ablation was performed for each PIFA catheter and its corresponding catheter (Table 3).
- maximum power was set to 50 W and catheter tip temperature limit set to 55° C.
- Peak catheter tip temperatures were statistically different between PIFA and standard 4 mm catheters, 53 ⁇ 3° C. vs. 46 ⁇ 2° C. respectively (p ⁇ 0.001); however, the PIFA 4 mm catheter was not significantly limited by these peak temperatures, as it was able to achieve a maximum power of 49 ⁇ 1 W, which was not statistically different from the 50 W achieved by the 4 mm standard catheter.
- Lesion sizes were larger with the 4 mm PIFA, measuring 169.7 mm 3 , compared to 94.2 mm 3 for a standard catheter (p ⁇ 0.001).
- Results were similar for the 8 mm and irrigated PIFA catheters, compared to their corresponding catheters, using temperature control mode ablation. While catheter tip temperatures were higher for the PIFA catheters (Table 3), power delivery was not limited, and maximum powers (70 W for 8 mm, 50 W for irrigated tip) were achieved and larger lesions were created.
- FIG. 5A displays the mean starting and ending impedance measurements before and after ablation using a 4 mm PIFA catheter and open irrigated catheter.
- PIFA catheter-ablated myocardial tissues had higher starting and ending impedance with larger impedance reductions observed with ablation. These effects were also observed for the 8 mm PIFA at 30 and 60 Watts, when compared to the 8 mm standard catheter ( FIG. 5B ).
- the partially insulated ablation catheters have been shown herein to exhibit significantly altered radiofrequency ablation properties. Specifically, in the examples, ablation of myocardial tissue with partially insulated catheters resulted in an increase in ablation lesion size beneath the non-insulated PIFA surfaces, while myocardial tissue on the insulated sides were protected and had only trivial evidence of ablation.
- the larger lesions created by the non-insulated sides of the PIFA catheters were associated with a larger reduction in electrical impedance and improved thermal conductivity below the non-insulated surfaces. Lesion sizes were insignificant and temperatures were lower for the insulated surfaces of PIFA catheters.
- the effective current density on the remaining non-insulated metallic tip used for RF energy delivery is greatly increased, therefore leading to larger and, depending on catheter orientation, asymmetric lesions.
- the non-irrigated PIFA catheters also demonstrated significant comparative reduction in RF heating of tissue along the insulated side. However, this reduction in heating on the insulated side was not significant for the open irrigated PIFA catheter.
- RF energy is routinely performed for the treatment of a variety of arrhythmias. All radiofrequency ablation catheters are radially symmetric at the catheter tip cylinder, thus allowing for circumferential RF.
- catheter design allows for a more tailored approach during RF ablation in which circumferential ablation is not desired.
- RF energy restricted to a single side of the catheter may prevent complications due to unintended collateral injury to vital structures adjacent to the targeted cardiac tissue. This situation is most commonly observed during RF application near the AV node, in the epicardium, and near the phrenic nerve.
- a circumferential catheter tip may lead to unintended loss of RF to surrounding blood flow, thus decreasing the efficacy of ablation.
- An insulated catheter, where RF energy is concentrated to a single side, will allow for a more effective ablation at lower powers, potentially improving safety. It will also permit RF delivery deeper into tissues and is therefore useful for difficult arrhythmias arising from deep structures such as the septum, papillary muscle, and cavo-tricuspid isthmus.
- An insulated catheter has been designed and engineered, using a silicone-vinyl coating on half the surface of a catheter tip to direct RF energy preferentially and asymmetrically to the non-insulated side of the catheter tip.
- Ablation studies with these PIFA catheters have met two principal objectives for clinical applicability. First, it is shown herein that the insulated sides of the PIFA catheters have decreased temperature changes and minimal tissue injury when RF ablation is delivered. Secondly, it is shown that the non-insulated sides of these catheters deliver a greater degree of tissue heating with less power, which results in larger ablation lesions.
- Partially insulated ablation catheters resulted in increased lesion sizes from applied radiofrequency energy on the non-insulated surfaces of the catheters in an ex vivo model, due to increased RF current density. Partial insulation of an ablation catheter significantly altered the electrical properties at the tip-tissue interface of targeted myocardial tissue and resulted in the increased degree of RF heating. In addition, tissue adjacent to the insulated surfaces of the catheters had lower injury characteristics, with smaller ablation lesion sizes and lower temperatures.
- FIG. 23 shows an illustration of an RF venting catheter design.
- the vented ablation catheter is insulated over its superior aspect, thereby focusing ablation to the lower aspect while allowing limited heat dissipation through the insulation.
- the vented catheter has a plurality of perforations, or vents or pores, that provide limited exposure to the metal beneath the insulation.
- the addition of RF venting to the catheter insulation augments catheter cooling without compromising the safety profile and the intended protective role of the thermally conductive electrical installation.
- the pore size can be tailored to address specific applications or needs. For example, larger pores will increase the exposure of the metal beneath the catheter insulation to the fluid in the area surrounding the ablation site. Thus, it is envisioned that pore sizes can vary from very fine perforations that are sparsely distributed over the surface of the insulated metal to large perforations that leave the surface of the metal largely exposed.
- the size of the gaps in the insulation can be important. For example, the spectrum of possible coating designs include ones like a fish net (very large “holes”) and ones like perforated leather (very small holes).
- the insulation on the tip of the catheter essentially interferes with contact between the tip and the tissue, but allows for contact with external blood/saline for controlled RF leaking or venting when utilizing a vented design such as is proposed, thus effectively diminishing the concentration of RF current at the tip-tissue interface in a controlled manner. This augments the safety of the catheter.
- Partial insulation of an irrigated catheter tip with silicone and AOBN exhibited improved performance, and reduced tip temperature limitations, when compared to vinyl, vinyl-silicone, and polyurethane partial insulation. Significant differences in lesion volumes and temperature-limited powers were noted for control, silicone and AOBN tips (Tables 6 and 7). In addition, steam pops were significantly higher for silicone but not AOBN. AOBN created larger lesions, compared to controls.
- Example 11 Provided of Bundle of His and AV Node During RF Ablation with an Externally Irrigated PIFA Catheter in an In Vivo Porcine Model
- PIFA catheter can potentially improve safety is in the ablation of AVNRT, where ablation of the slow pathway is in the triangle between the tricuspid valve and the coronary sinus ( FIG. 26 ), but the superior side of a standard ablation catheter applies unnecessary and unsafe RF towards the AV node.
- the insulated superior aspect of the PIFA mitigates this collateral damage to the AV node.
- Example 12 Provides Phrenic Nerve During RF Ablation with an Externally Irrigated PIFA Catheter in an In Vivo Porcine Model
- PIFA PIFA ablation near the phrenic nerve, both during atrial fibrillation and VT ablations.
- control ablations denoted by dark lesion tags
- PIFA caused statistically significant fewer loss of phrenic nerve capture compared to controls ( FIG. 30 ).
- Radiofrequency ablation with partially insulated ablation catheters results in significantly altered tissue heating and lesion properties.
- ablation of myocardial tissue with partially insulated catheters resulted in an increase in ablation lesion size and geometry beneath the non-insulated catheter tip surfaces, while myocardial tissue on the insulated sides were protected and had only minimal evidence of exposure to RF energy.
- the larger and asymmetric lesions created by the PIFA catheters were associated with a larger reduction in electrical impedance, which was likely due to an increase in the RF current density.
- the very thin coating of electrical insulation using a thermally conductive material resulted in insignificant tip temperatures given the same amount of power despite the lower amount of electrically active surface area compared to standard catheters using clinically relevant power settings.
- the effective current density on the remaining non-insulated metallic tip used for RF energy delivery is greatly increased, therefore leading to larger and, depending on catheter orientation, asymmetric lesions.
- the non-irrigated PIFA catheters also demonstrated significant comparative reduction in RF heating of tissue along the insulated side. However, this reduction in heating on the insulated side was not significant for the open irrigated PIFA catheter.
- RF energy is routinely performed for the treatment of a variety of arrhythmias. All radiofrequency ablation catheters are radially symmetric at the catheter tip cylinder, thus allowing for circumferential RF.
- catheter design allows for a more tailored approach during RF ablation in which circumferential ablation is not desired.
- RF energy restricted to a single side of the catheter may prevent complications due to unintended collateral injury to vital structures adjacent to the targeted cardiac tissue. This situation is most commonly observed during RF application near the AV node, in the epicardium, and near the phrenic nerve.
- a circumferential catheter tip may lead to unintended loss of RF to surrounding blood flow, thus decreasing the efficacy of ablation.
- An insulated catheter, where RF energy is concentrated to a single side, will allow for a more effective ablation at lower powers, potentially improving safety. It will also permit RF delivery deeper into tissues and is therefore useful for difficult arrhythmias arising from deep structures such as the septum, papillary muscle, and cavo-tricuspid isthmus.
- An insulated catheter has been designed and engineered using a thin coating of thermally conductive material on half the surface of a catheter tip to direct RF energy preferentially and asymmetrically to the non-insulated side of the catheter tip.
- Ablation studies with these PIFA catheters have confirmed our two main hypotheses for its clinical applicability.
- the insulated sides of the PIFA catheters have decreased temperature changes and minimal tissue injury when RF ablation is delivered.
- the non-insulated sides of these catheters deliver a greater degree of tissue heating with less power resulting in larger ablation lesions without the limitation of higher tip temperatures.
- a and “an” are used in the sense that they mean “at least one”, “at least a first”, “one or more” or “a plurality” of the referenced components or steps, unless the context clearly dictates otherwise.
- a cell includes a plurality of cells, including mixtures thereof.
- compositions and methods are intended to mean that the products, compositions and methods include the referenced components or steps, but not excluding others. “Consisting essentially of” when used to define products, compositions and methods, shall mean excluding other components or steps of any essential significance. Thus, a composition consisting essentially of the recited components would not exclude trace contaminants and pharmaceutically acceptable carriers. “Consisting of” shall mean excluding more than trace elements of other components or steps.
Abstract
Partially insulated focused ablation (PIFA) catheters using thermally conductive materials have differential radiofrequency (RF) heating and thereby allow for tailored RF application. Open-irrigated, 4 mm, and 8 mm RF ablation catheters were partially insulated by coating half their surfaces with a layer of vinyl, silicone, vinyl-silicone, polyurethane, or a composite of aluminum oxide/boron nitride (AOBN). RF ablation using catheter tips partially coated with a thermally conductive insulation material such as AOBN results in larger ablation lesion volumes without being limited by standard temperature controls. Partial insulation of the catheter tip is able to protect adjacent critical structures during in vivo ablation.
Description
This application claims the benefit of U.S. Provisional Application No. 62/079,992, filed Nov. 14, 2014, and U.S. Provisional Application No. 62/114,371, filed Feb. 10, 2015.
This invention relates to medical devices. More specifically, this invention relates to partially insulated radiofrequency ablation catheter tips.
Cardiac arrhythmias comprise a major health problem; ventricular arrhythmias are the number one cause of death in the U.S. Cardiac ablation using radiofrequency (RF) energy is the standard treatment for most arrhythmias refractory to medical therapy. RF current heats tissue via resistive heating of a thin rim of tissue that is in direct contact with the ablation tip [Nath S, et al., J Cardiovasc Electrophysiol. 1994; 5:863-876]. Deeper tissue heating is due to passive thermal conduction from this small area of volume heating, [Haines D. J Cardiovasc Electrophysiol. 2004; 15:52-S11] and ablation lesion size is related to the temperature at the electrode-tissue interface, size of the ablation tip, RF duration, and tissue contact [Langberg J J, et al., Pacing Clin Electrophysiol. 1990; 13:1242-1248; Otomo K, et al., J Cardiovasc Electrophysiol. 1998; 9:47-54; Haines D E, et al., Circulation. 1990; 82:1034-1038].
One limitation of RF ablation is the inability to achieve durable lesions with the safe delivery of low power to myocardial tissue. Furthermore, ablation may be constrained due to anatomic considerations, such as proximity to critical structures, including the atrioventricular (AV) node, phrenic nerve, or pericardium [Hintringer F, et al., Circulation. 1995; 92:3490-3496; Yong Ji S, et al., J Cardiovasc Electrophysiol. 2013; Killu A M, et al., Heart Rhythm. 2013; 10:1613-1621]. In addition, when ablating myocardial tissue, only one side of the ablation catheter is adjacent to the tissue being targeted; RF from the contralateral side is either lost due to circulating blood or can potentially injure adjacent tissue.
Radiofrequency (RF) ablation has revolutionized the treatment of cardiac arrhythmias over the last couple decades. However, significant limitations remain, in terms of both safety and efficacy of RF ablation. Risks include collateral damage to vital cardiac and non-cardiac structures and unnecessary ablation of healthy tissue. Furthermore, durable and effective ablation lesions can be incomplete, particularly for challenging arrhythmias, such as atrial fibrillation and ventricular tachycardia.
All radiofrequency ablation catheters have radial symmetry at the catheter tip cylinder allowing for the delivery of RF at all sites of the catheter. However, there are many circumstances where RF energy applied in an unrestricted manner from the circumferential catheter tip cylinder results in complications due to unintended collateral injury to structures adjacent to the targeted cardiac tissue. This situation is most commonly observed during RF application near the atrioventricular node and in the epicardium. When energy is applied to tissue below the AV node, RF energy is inevitably delivered higher than what is targeted. Likewise, catheters used for the delivery of RF energy on the epicardium deliver the energy circumferentially through a metal tip. This inefficient method results in the unnecessary heating and ablation of the pericardium and often results in pericarditis (a common complication of the procedure).
What is needed to overcome these significant limitations is a catheter design that effectively delivers RF energy to the targeted tissue while avoiding collateral damage to adjacent tissue. However, in view of the art considered as a whole at the time the present invention was made, it was not obvious to those of ordinary skill in the field of this invention how the shortcomings of the prior art could be overcome.
The long-standing but heretofore unfulfilled need for is now met by a new, useful, and nonobvious invention. There is an unmet need in catheter design that allows for a more tailored approach during RF ablation in which circumferential ablation is not desired. There are many circumstances where RF energy restricted to a single side of the catheter may prevent complications due to unintended collateral injury to vital structures adjacent to the targeted cardiac tissue. This situation is most commonly observed during RF application near the atrioventricular (AV) node, in the epicardium, and near the phrenic nerve. Furthermore, a circumferential catheter may lead to unintended loss of RF to surrounding blood flow, thus decreasing the efficacy of ablation. An insulated catheter, where RF energy is concentrated to a single side, will allow for a more effective ablation at lower powers, potentially improving safety. It will also permit RF delivery deeper into tissues and is therefore useful for difficult arrhythmias arising from deep structures such as the septum, papillary muscle, and cavo-tricuspid isthmus.
In a first aspect the present invention provides an ablation catheter system for ablating the tissue of a body, such as cardiac tissue. The ablation catheter system includes a catheter body including a distal tip, at least one ablation electrode at the distal tip of the catheter body and an insulating layer disposed over a portion of the ablation electrode, wherein the insulating layer prevents or reduces the application of heat to tissues adjacent to the site of ablation. The distal tip of the ablation catheter can be rotatable. By making the tip and/or insulation rotatable a user can alter the orientation of the insulating layer.
The insulating layer of the first aspect can be a thermally conductive electrical insulation. In an advantageous embodiment the insulating layer can be aluminum oxide, boron nitride, aluminum oxide and boron nitride composite, silicone, vinyl, polyurethane, carbon nanotubes oriented perpendicular to the RF current, graphite embedded in thermal epoxy or diamond embedded in thermal epoxy. In a particularly advantageous embodiment the insulating layer is an aluminum oxide/boron nitride (AOBN) coating. In further advantageous embodiments the insulating layer is applied to about one-half of the surface area of the tip.
The tip of the ablation catheter system can be a non-irrigated about 4 mm RF catheter tip, non-irrigated 8 mm RF catheter tip, and an open-irrigated RF ablation catheter tip. In an advantageous embodiment the insulating layer covers the superior aspect of the catheter tip. In other words, the aspect of the tip away from the site of ablation is covered with insulating material. In another embodiment the insulating layer covers about one-half of the catheter tip.
The ablation catheter system can include one or more ports in the insulation to allow for irrigation through the insulating layer. Similarly, the ablation catheter system can employ an insulating layer that has a plurality of holes dispersed over the insulating layer thereby exposing portions of the metal ablation tip through the holes in the insulating. This allows for venting from the metal underneath the insulation.
In a second aspect the present invention provides a second ablation catheter system for ablating the tissue of a body. The ablation catheter system of the second aspect includes a catheter body including a distal tip, at least one ablation electrode at the distal tip of the catheter body, and an insulating layer disposed over a portion of the ablation electrode. The insulating layer has a plurality of holes dispersed over the insulating layer to expose portions of the metal ablation tip through the holes in the insulating layer. The insulating layer prevents or reduces the application of heat to tissues adjacent to the site of ablation.
The insulating layer of the first aspect can be a thermally conductive electrical insulation. In an advantageous embodiment the insulating layer can be aluminum oxide, boron nitride, aluminum oxide and boron nitride composite, silicone, vinyl, polyurethane, carbon nanotubes oriented perpendicular to the RF current, graphite embedded in thermal epoxy or diamond embedded in thermal epoxy. In a particularly advantageous embodiment the insulating layer is an aluminum oxide/boron nitride (AOBN) coating. In further advantageous embodiments the insulating layer is applied to about one-half of the surface area of the tip.
The tip of the ablation catheter system can be a non-irrigated about 4 mm RF catheter tip, non-irrigated 8 mm RF catheter tip, and an open-irrigated RF ablation catheter tip. In an advantageous embodiment the insulating layer covers the superior aspect of the catheter tip. In other words, the aspect of the tip away from the site of ablation is covered with insulating material. In another embodiment the insulating layer covers about one-half of the catheter tip.
The ablation catheter system can include one or more ports in the insulation to allow for irrigation through the insulating layer.
In a third aspect the present invention provides an interchangeable ablation catheter tip for a radiofrequency ablation catheter. The interchangeable ablation catheter tip includes an ablation electrode which has an insulating layer disposed over a portion of the ablation electrode. The insulating layer prevents or reduces the application of heat to tissues adjacent to the site of ablation. The interchangeable ablation catheter tip is adapted to releasably engage a distal tip of a radiofrequency catheter body, thus facilitating the exchange of catheter tips on a catheter.
In certain embodiments the tip can be a non-irrigated about 4 mm RF catheter tip, a non-irrigated 8 mm RF catheter tip, or an open-irrigated RF ablation catheter tip.
In an advantageous embodiment the insulating layer covers the superior aspect of the catheter tip. In other words, the aspect of the tip away from the site of ablation is covered with insulating material. In another embodiment the insulating layer covers about one-half of the catheter tip.
The interchangeable ablation catheter tip can include one or more ports in the insulation to allow for irrigation through the insulating layer. Similarly, the interchangeable ablation catheter tip can employ an insulating layer that has a plurality of holes dispersed over the insulating layer thereby exposing portions of the metal ablation tip through the holes in the insulating. This allows for venting from the metal underneath the insulation.
The insulating layer of the interchangeable ablation catheter tip can be a thermally conductive electrical insulation. In an advantageous embodiment the insulating layer can be aluminum oxide, boron nitride, aluminum oxide and boron nitride composite, silicone, vinyl, polyurethane, carbon nanotubes oriented perpendicular to the RF current, graphite embedded in thermal epoxy or diamond embedded in thermal epoxy. In a particularly advantageous embodiment the insulating layer is an aluminum oxide/boron nitride (AOBN) coating.
For a fuller understanding of the invention, reference should be made to the following detailed description, taken in connection with the accompanying drawings, in which:
Partially insulated focused ablation (PIFA) catheters using thermally conductive materials have differential radiofrequency (RF) heating and thereby allow for tailored RF application. PIFA catheters can minimize risk of injury to critical structures, such as the phrenic nerve and AV node, during ablation. Open-irrigated, 4 mm, and 8 mm RF ablation catheters were partially insulated by coating half their surfaces with a layer of vinyl, silicone, vinyl-silicone, polyurethane, or a composite of aluminum oxide/boron nitride (AOBN). The various coatings exhibited different tip temperature performances, with silicone and AOBN displaying fewer tip temperature limitations than vinyl, vinyl-silicone, and polyurethane. Significant differences in lesion volumes and temperature-limited powers were noted for control, silicone and AOBN tips. In addition, steam pops were significantly higher for silicone but not AOBN. Compared to standard ablation, AOBN-coated PIFA catheters were able to minimize injury to the phrenic nerve and AV node. Standard ablation near the AV node caused complete heart block whereas PIFA ablation did not. RF ablation using catheter tips partially coated with a thermally conductive insulation material such as AOBN results in larger ablation lesion volumes without being limited by standard temperature controls. Partial insulation of the catheter tip is able to protect adjacent critical structures during in vivo ablation.
Effective radiofrequency ablation (RFA) can be impacted by the size of the ablation catheter tip, temperature at the electrode-tissue interface, RF duration, and tissue contact. A partially insulated catheter tip is disclosed and shown to impact ablation lesion size and shape, thereby providing additional tools to tailor the ablation to the user's needs. When insulation is partially applied to an ablation electrode, the insulation alters RF lesion geometry with minimal effect on tip temperatures. Existing catheters were modified by coating a portion of the metallic tip using a thin layer of insulation that also is thermally conductive. This allows for a more tailored cardiac ablation by improving heating under the non-insulated side of the catheter while decreasing undesired RF-mediated injury from the insulated side.
Insulation materials were investigated to demonstrate their effect on asymmetrical lesion formation while protecting the tissue adjacent to the insulated aspect of the ablation catheter tip. Using these insulation materials, we performed in vivo ablation near critical structures to demonstrate the ability of PIFA to protect these structures.
Catheter ablation of cardiac tissue with radiofrequency (RF) energy is routinely performed for the treatment of a variety of arrhythmias. All radiofrequency ablation catheters are radially symmetric at the catheter tip cylinder, thus allowing for circumferential RF. However, there is an unmet need in catheter design that allows for a more tailored approach during RF ablation in which circumferential ablation is not desired. There are many circumstances where RF energy restricted to a single side of the catheter may prevent complications due to unintended collateral injury to vital structures adjacent to the targeted cardiac tissue. This situation is most commonly observed during RF application near the AV node, in the epicardium, and near the phrenic nerve. Furthermore, a circumferential catheter tip may lead to unintended loss of RF to surrounding blood flow, thus decreasing the efficacy of ablation. An insulated catheter, where RF energy is concentrated to a single side, will allow for a more effective ablation at lower powers, potentially improving safety. It will also permit RF delivery deeper into tissues and is therefore useful for difficult arrhythmias arising from deep structures such as the septum, papillary muscle, and cavo-tricuspid isthmus.
An insulated catheter has been designed and engineered, using a silicone-vinyl coating on half the surface of a catheter tip to direct RF energy preferentially and asymmetrically to the non-insulated side of the catheter tip. Ablation studies with these PIFA catheters have met two principal objectives for clinical applicability. First, it is shown herein that the insulated sides of the PIFA catheters have decreased temperature changes and minimal tissue injury when RF ablation is delivered. Secondly, it is shown that the non-insulated sides of these catheters deliver a greater degree of tissue heating with less power, which results in larger ablation lesions.
Selective electrical insulation applied to an ablation electrode to protect non-targeted myocardial tissue or structures alters RF lesion geometry with minimal effect on tip temperatures. Catheters were modified to influence RF energy delivery by coating a portion of the metallic tip using a thin layer of electrical insulation that also is thermally conductive. FIGS. 12, 15-20 and 23-24 show exemplary coating patterns. Referring to FIG. 12 , a plurality of different coating patterns (20) are disclosed. Cather tips 20 a and 20 d have a coating over roughly one-half of the surface of the tip, with the coating applied to superior side of the tip, or the surface area that would be away from the tissue being ablated. Other coating patterns are possible. For instance, catheter tip 20 b has additional insulation completely covering the distal portion of the catheter tip, while catheter tips 20 c and 20 e have the distal portion of the catheter tip exposed. While catheter tip 20 a shows roughly 50% of the tip covered with insulation, it is contemplated that roughly 25%, 30%, 40%, 50%, 60%, 70% or 75% of the tip could be covered by insulation depending upon the application and needs of the user. FIG. 17 shows a partially insulated open irrigated 3.5 mm catheter tip having a thin layer of insulation 22 coating the metal surface 21 (having holes 23) of the catheter 20. Similarly, FIG. 23 shows an ablation catheter 10 with a catheter tip 20 having a thin layer of insulation 22 over the metal 21 of the catheter tip 20. The thin layer of insulation 22 has a plurality of holes 22 a through the insulation to allow for venting from the metal 21. The vents 22 a are shown in more detail in FIG. 24 .
Examples of suitable coating materials include aluminum oxide, boron nitride, aluminum oxide and boron nitride composite, silicone, vinyl, polyurethane, carbon nanotubes placed perpendicular to RF current, graphite embedded in thermal epoxy and diamond embedded in thermal epoxy. These coatings would be over a tip constructed of a material such as Gold, Platinum, and Platinum-Iridium and gold and platinum alloys. The modification of the coating allows for a more tailored cardiac ablation by improving heating under the non-insulated side of the catheter while decreasing undesired RF-mediated injury from the insulated side. Partially insulated, focused ablation (PIFA) catheters were created whereby one side of various ablation catheter tips (4 mm, 8 mm, and open irrigated) was insulated with a very thin layer of thermal adhesive coating to eliminate RF conductivity on this side, while also allowing for convective cooling of the catheter tip to prevent tip temperature limitations.
A catheter has also been developed that can be easily converted from the current radially symmetric catheter tip into an insulated tip. This catheter design allows operators to exchange or convert from the current radial tip technology to a partially insulated tip. Exemplary exchangeable tips are shown in FIGS. 12, 15-17, 19-20 and 23-24 . The design, which can include a rotating insulated cover, allows for either side of the catheter to be insulated, thereby maintaining the bi-directionality of the catheter. This catheter will allow clinicians to tailor their ablation strategy according to the type of cardiac tissue being targeted and depending on the arrhythmia of interest. This technology was developed using the standard 4 mm ablation catheter, but the design can easily be accommodated to the 8 mm catheter and the irrigated tip catheter. Applying the technology to irrigated tip catheters allows for even more directed and deeper ablation lesions, thereby making durable lesions for treating a variety of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia. In a first embodiment the insulated cover is in a fixed orientation with respect to the catheter tip, but further embodiments include a rotating insulated cap around the ablation catheter tip. Use of a rotating insulated cap around the ablation catheter tip allows the use of all sides of the ablation catheter, with the operators tailoring their partial insulation in the direction that they prefer. This partially insulated, rotating cap can be applied to the standard 4 mm catheter, as well as the 8 mm catheter and an irrigated tip catheter.
External irrigation is also contemplated. There may be concerns over recycling of lumen catheters. If irrigation tubing is moved to the outside of a catheter tip, it could also serve as insulation. FIGS. 21 and 22 disclose examples of tips with external irrigation tubing.
Additional interchangeable tips are also contemplated. These include:
-
- 0.5 mm fine mapping tip
- Solid 4 mm with different regional insulation patterns (
SN 1,SN 2,SN 3, SN 4 (AVNRT)) - Open Irrigated 3.5 mm (“Thimble”)
- Open Irrigated 3.5 mm (“Thimble”) different regional insulation patterns
- Repeat on the 8 mm
In addition, the tip designs proposed herein can be applied to the following tip types: peanut, tapered, deformable “Blob” tip, CNT coated tip, gold or copper tip, needle tip and proximally coated 10 mm tip (electrical insulation with high thermal conductivity).
Tailored and facilitated RF ablation is paramount and is an unmet need in ablation technology. Different areas of the heart have diverse physical properties and react differently to ablation. Currently, RF ablation catheters all have the same design, with their inherent limitations, and one catheter tip design is not meant to treat all different types of tissue or arrhythmia. The only “tailoring” that can be currently performed with these catheters is to manually orient them differently or to titrate the amount of energy being delivered. The development of an insulated cover will allow for another dimension of tailoring, making ablation safer, while at the same time more effective. This technology has the potential for altering the practice of an entire field of therapeutics with a large demand of services in a high volume of patients.
This catheter could be considered for any catheter ablation procedure where focused ablation and/or tailored protective insulation are preferred. The arrhythmias that may be treated using this catheter include atrial flutter, AV nodal reentrant tachycardia, supraventricular tachycardia, atrial fibrillation, and ventricular tachycardia.
Ex-Vivo Model
The experimental protocols employed herein have been approved by the Institutional
Animal Care and Use Committees of the University of Colorado and University of Chicago. An ex vivo model consisting of viable bovine myocardium, a circulating saline bath at 37 degrees Celsius, a submersible load cell, and a deflectable sheath was assembled. The circulating bath utilized a perfusion pump designed for cardiac bypass and circulated fluid in a saline bath at a rate of 5 L per minute. A load cell was submersed in the bath and contained a section of viable bovine ventricular myocardium excised within 1 hour of experimentation. This load cell measured force applied to the overlying myocardial tissue and was used to standardize application of energy. This ex vivo model has been validated and described in further detail elsewhere [Olson M D, et al., J Interv Card Electrophysiol 0.38:123-129].
Catheter Modification with Electrical Insulation Using Thermally Conductive Materials
A non-irrigated 4 mm RF catheter, non-irrigated 8 mm RF catheter, and an open-irrigated RF ablation catheter (Biosense-Webster, Diamond Bar, Calif.) were partially insulated by coating half their surfaces with a thin layer of thermally conductive material, including either a layer of vinyl, silicone, vinyl-silicone, polyurethane, or a composite of aluminum oxide/boron nitride (AOBN) (See e.g. FIGS. 12, 15-20 and 23 ). The coatings were created with an epoxy allowed to dry, leaving a thin (<0.1 mm) layer covering half of the metallic tip. For the externally irrigated catheter, the existing tip fenestrations were preserved to allow for active cooling with saline irrigant on all sides of the catheter. These PIFA catheters or their corresponding non-insulated catheters (Biosense-Webster, Diamond Bar, Calif.) were positioned with 10 grams of force in a parallel position using a deflectable sheath (Agilis, St. Jude Medical). The most effective insulation coating, AOBN, a very effective insulation coating, was further modified by adding vents into the coating to allow for thermal release/venting (FIGS. 23 and 24 ). Ablation with this vented AOBN was compared to standard AOBN coating, and temperatures were recorded.
Delivery of Radiofrequency Energy Applied to Myocardium
Using varying powers (20, 30, and 40 Watts) under power control mode, a series of ablation lesions with each catheter was created on the recently excised bovine myocardium, with the insulated or non-insulated side parallel to the myocardium. A separate set of lesions was created using temperature control mode for maximum power (50 Watts for 4 mm and irrigated tip and 70 W for 8 mm), with tip temperature limits set at ≤55° C. (4 mm), ≤60° C. (8 mm) and ≤45° C. (irrigated tip), for 60-second ablations. The number of lesions applied per ventricular section depended upon the available endocardial surface. No lesions were placed over or in immediate proximity of papillary muscles (5 mm) or within immediate proximity of other lesions. Furthermore, no lesions were placed within 1 cm of section edge.
In Vivo Epicardial Ablation and Assessment of Pericardial Injury
Three Yorkshire pigs were anesthetized and intravenous lidocaine (50-100 mg) was used intraoperatively for prophylaxis of ventricular arrhythmias. Epicardial access was obtained under fluoroscopy using a 17-gauge Pajunk needle (Pajunk Medical Systems, Norcross, Ga.) and a 9 French sheath was placed in the epicardium. An electroanatomic map of the entire epicardium was created using the CARTO3 mapping system (Biosense-Webster, Diamond Bar, Calif.). Via the 9 French sheath, a PIFA irrigated tip catheter and a standard irrigated tip catheter were used to deliver PIFA and standard irrigated “control” ablation lesions on the epicardium in each pig. Ablations were delivered at 50 W for 30 seconds with the same amount of force as measured by SmartTouch technology on the RF catheters (Biosense-Webster, Diamond Bar, Calif.); ablation lesions were tagged by the electroanatomic mapping system. Ablations with both PIFA and standard catheters were performed in the same epicardial region. Saline irrigant was suctioned from the epicardium after each ablation. Following ablation, animals were sacrificed and the hearts and their pericardium were immediately explanted and fixed in formalin. Gross pathology was performed; pericardial tissue were assessed for injury, and epicardial ablation lesions were analyzed.
In Vivo Ablation of AV Node and Phrenic Nerve
Yorkshire pigs (n=12) were anesthetized and intravenous lidocaine (50-100 mg) or amiodarone (150 mg IV bolus followed by a 1 mg/min infusion) was used intraoperatively for prophylaxis of ventricular arrhythmias. Epicardial access was obtained under fluoroscopy using a 17-gauge Pajunk needle (Pajunk Medical Systems, Norcross, Ga.) and a 9 French sheath was placed in the epicardium. An electroanatomic map of the superior vena cava (SVC), right atrium (RA), and epicardium was created using the CARTO3 mapping system (Biosense-Webster, Diamond Bar, Calif.).
A decapolar catheter was used to pace and capture the right and left phrenic nerves, either in the endocardium or epicardium. A force-sensing PIFA irrigated tip catheter and a standard force-sensing irrigated tip catheter were used to deliver alternating PIFA and standard irrigated “control” ablation lesions directly below the site of phrenic nerve capture. After each ablation, pacing and capture of the phrenic nerve was moved inferiorly. Loss of phrenic nerve capture, time to loss of phrenic nerve capture, and time to phrenic nerve recovery (as established by return of phrenic nerve capture) were recorded and compared for PIFA and control. During PIFA ablation, the insulated aspect of the catheter tip was superiorly oriented toward the phrenic nerve. Ablations were delivered at 50 W for 30 seconds with the same amount of force as measured by SmartTouch technology on the RF catheters (Biosense-Webster, Diamond Bar, Calif.); ablation lesions were tagged by the electroanatomic mapping system. Saline irrigant was suctioned from the epicardium after each ablation.
The Bundle of His was mapped on the septal tricuspid annulus. Once the His region was annotated, either a standard irrigated catheter or a PIFA catheter was placed directly below the His and ablation was performed. AV block, time to AV block, and recovery of conduction after immediate cessation of ablation, if any, were recorded. During PIFA ablation, the insulated aspect of the catheter tip was superiorly oriented toward the His. Ablations were delivered at 50 W for 30 seconds with the same amount of force as measured by SmartTouch technology on the RF catheters (Biosense-Webster, Diamond Bar, Calif.); ablation lesions were tagged by the electroanatomic mapping system.
Ablation Lesion Volume Measurements
Lesion volumes were acquired by analyzing tissue sections with a digital micrometer.
Single lesion volumes were calculated using the equation for an ellipsoid. For each lesion, maximum depth (A), maximum width (W), and lesion surface diameter (D) were measured.
Volume of an Ellipsoid Ablation Lesion:
Where D=maximum depth, W=maximum width, and L=Lesion surface diameter
Ablation Lesion Volume Measurements
Lesion volumes were acquired by analyzing tissue sections with a digital micrometer. Single lesion volumes were calculated using the equation for an oblate ellipsoid. For each lesion, maximum depth (A), maximum diameter (B), depth at maximum diameter (C), and lesion surface diameter (D) were measured.
Equation 2: volume of oblate ellipsoid
Where A=maximum depth, B=maximum diameter, C=depth at maximum diameter and D=lesion surface diameter.
Tissue Temperature Analysis
T-type thermocouple wires were inserted horizontally into myocardium at 3 mm and 5 mm depths and beneath the ablation surface during ablations with the standard catheter or non-insulated aspect of the PIFA catheter parallel to the myocardium (FIGS. 1 and 2 ). Furthermore, T-type thermocouple wires were placed horizontally into myocardium at 1 mm, 2 mm, and 4 mm distances from each side of the ablation catheter, with the ablation catheter oriented as shown in FIG. 2 in relationship to the myocardium. Thermocouple analogue inputs were converted to digital signals using LabView software (version 7.0). Temperatures were recorded in a continuous fashion throughout the 60 seconds of RF application at a rate of 5 Hertz. Peak tissue temperature was defined as the maximum temperature reading during RF application. Initial temperature rise rate was defined as the amount of temperature rise in the first 30 seconds and area under curve (AUC) corresponded to total temperature change over total RF time (60 seconds). RF applications that generated steam pops were excluded from temperature curve analysis.
Statistical Analysis
SPSS software was used to perform all calculations. The Analysis of Variance (ANOVA) test was used to compare continuous variables and the Chi-square test was used for dichotomous comparisons in lesion characteristics from PIFA catheter-ablated myocardium vs. lesions ablated by corresponding non-insulated catheters.
At 20 W, ablation lesions (n=12) created by the 4 mm PIFA catheter were significantly larger, 101 mm3 vs. 35 mm3 (p<0.001; n=18). This effect was similar for the 8 mm PIFA catheter, compared to a standard 8 mm catheter, at varying powers from 30 W to 60 W (the standard 8 mm catheter created negligible lesions at 20 W, and these were unable to be used for comparisons to the 8 mm PIFA lesions at 20 W). The same phenomenon was observed for the open irrigated catheter at 20 W, with the PIFA irrigated catheter creating volumes of 75.4 mm3, compared to 22.1 mm3 (p<0.001) for the standard open irrigated catheter. Ablation lesions could not be created on tissue exposed to the insulated side of each PIFA catheter. Tables 1 and 2 show the differences in ablation lesion shape and size, depending on the catheter used. The tip temperatures for all ablation lesions created with all catheters tested were <55° C. (4 mm and 8 mm) and <45° C. (irrigated tip) at the fixed powers tested.
TABLE 1 |
Myocardial Ablation Lesion Characteristics after Radiofrequency Energy Applied |
at 20 Watts for 60 |
Standard |
4 mm | P value | Standard | | P value | |||
4 mm | PIFA | (4 mm vs. | open | open | (Open | ||
| Catheter | PIFA | 4 | irrigated | irrigated | irrigated | |
(N =18) | (N =12) | mm) | (N =18) | (N =14) | vs. PIFA) | ||
Maximum Depth (mm) | 2.3 ± 0.6 | 4.8 ± 0.3 | <0.001 | 1.8 ± 0.4 | 4.6 ± 0.5 | <0.001 |
Maximum Width (mm) | 4.8 ± 0.9 | 5.6 ± 0.6 | =0.004 | 3.7 ± 0.4 | 4.8 ± 0.5 | <0.001 |
Surface Diameter (mm) | 5.9 ± 0.8 | 7.2 ± 0.6 | <0.001 | 6.2 ± 0.4 | 6.6 ± 0.6 | <0.05 |
Volume (mm3) | 35.0 ± 12.5 | 101.0 ± 17.4 | <0.001 | 22.1 ± 7.0 | 75.4 ± 17.2 | <0.001 |
Peak Temp at 3 mm (° C.) | 60.0 ± 7.4 | 75.3 ± 8.7 | <0.001 | 55.9 ± 4.5 | 71.6 ± 9.3 | <0.001 |
Peak Temp at 5 mm (° C.) | 47.4 ± 4.0 | 53.6 ± 4.7 | <0.001 | 51.9 ± 3.8 | 61.8 ± 8.9 | <0.001 |
TABLE 2 |
Myocardial Ablation Lesion Characteristics after Radiofrequency Energy with 8 |
mm Ablation Catheter, Applied at 30 W and 60 W for 60 Seconds |
30 W | 30 W | 30 W | 60 W | 60 W | 60 W | |
Standard | PIFA | P value | Standard | PIFA 8 | |
|
8 |
8 mm | (8 |
8 mm | mm | (8 mm vs. | |
Catheter | Catheter | vs. PIFA | Catheter | Catheter | PIFA 8 | |
(N = 14) | (N=15) | 8 mm) | (N = 16) | (N = 17) | mm) | |
Maximum Depth (mm) | 2.1 ± 0.4 | 3.9 ± 0.7 | <0.001 | 4.1 ± 0.6 | 5.6 ± 0.5 | <0.001 |
Maximum Width (mm) | 4.2 ± 0.3 | 4.2 ± 0.5 | =0.989 | 4.4 ± 0.4 | 5.4 ± 0.4 | <0.001 |
Surface Diameter (mm) | 9.0 ± 0.6 | 10.0 ± 0.9 | =0.002 | 9.4 ± 0.4 | 10.8 ± 0.8 | <0.001 |
Volume (mm3) | 40.9 ± 10.0 | 85.8 ± 18.1 | <0.001 | 90.1 ± 17.6 | 170.6 ± 26.5 | <0.001 |
Peak Temp at 3 mm (° C.) | 53.3 ± 4.5 | 72.4 ± 12.0 | <0.001 | |||
Peak Temp at 5 mm (° C.) | 49.1 ± 3.5 | 60.1 ± 7.4 | <0.001 | |||
Temperature control ablation was performed for each PIFA catheter and its corresponding catheter (Table 3). For the 4 mm catheters, maximum power was set to 50 W and catheter tip temperature limit set to 55° C. Peak catheter tip temperatures were statistically different between PIFA and standard 4 mm catheters, 53±3° C. vs. 46±2° C. respectively (p<0.001); however, the PIFA 4 mm catheter was not significantly limited by these peak temperatures, as it was able to achieve a maximum power of 49±1 W, which was not statistically different from the 50 W achieved by the 4 mm standard catheter. Lesion sizes were larger with the 4 mm PIFA, measuring 169.7 mm3, compared to 94.2 mm3 for a standard catheter (p<0.001). There were no steam pops. Results were similar for the 8 mm and irrigated PIFA catheters, compared to their corresponding catheters, using temperature control mode ablation. While catheter tip temperatures were higher for the PIFA catheters (Table 3), power delivery was not limited, and maximum powers (70 W for 8 mm, 50 W for irrigated tip) were achieved and larger lesions were created.
TABLE 3 |
Catheter Tip Temperatures and Lesion Characteristics with Radiofrequency |
Energy Delivery Using Temperature Control Mode |
Standard | 4 mm | Standard | 8 mm | Standard | Irrigated | ||||
4 mm | PIFA | P-value | 8 mm | PIFA | P-Value | Irrigated | PIFA | P-Value | |
N | 10 | 10 | 10 | 10 | 10 | 10 | |||
Temp Control | 55 | 55 | 60 | 60 | 45 | 45 | |||
(° C.) | |||||||||
Max Power | 50 | 50 | 70 | 70 | 50 | 50 | |||
Set (W) | |||||||||
Max Power | 50 ± 0 | 49 ± 1 | NS | 70 ± 0 | 70 ± 0 | NS | 50 ± 0 | 50 ± 0 | NS |
Achieved (W) | |||||||||
Peak Tip | 46 ± 2 | 53 ± 3 | p < 0.001 | 48 ± 2 | 53 ± 2 | p < 0.001 | 41 ± 1 | 42 ± 2 | p < 0.001 |
Temp (° C.) | |||||||||
Max Depth | 4.2 ± 0.5 | 5.7 ± 0.4 | p < 0.001 | 4.3 ± 0.5 | 6.6 ± 0.5 | p < 0.001 | 4.7 ± 0.4 | 6.2 ± 0.3 | p < 0.001 |
(mm) | |||||||||
Max Width | 5.8 ± 0.5 | 6.9 ± 0.6 | p < 0.001 | 6.1 ± 0.3 | 6.7 ± 0.5 | p = 0.010 | 5.9 ± 0.5 | 6.9 ± 0.3 | p = 0.010 |
(mm) | |||||||||
Surface | 7.2 ± 0.7 | 8.3 ± 0.6 | p = 0.002 | 9.3 ± 0.2 | 11.7 ± 0.8 | p < 0.001 | 7.2 ± 0.5 | 7.9 ± 0.6 | p < 0.001 |
Diameter | |||||||||
(mm) | |||||||||
Volume | 94.2 ± 23.3 | 169.7 ± 30.5 | p < 0.001 | 126.2 ± 12.7 | 270.6 ± 31.3 | p < 0.001 | 103.3 ± 15.8 | 176.5 ± 20.5 | p < 0.001 |
(mm3) | |||||||||
During a 60 second ablation at 20 Watts (power control mode), the mean temperatures recorded at 3 mm and 5 mm depths beneath the 4 mm ablation catheter tip were significantly higher with ablation using the PIFA catheter, compared to a standard 4 mm catheter (FIG. 3A ). This effect was seen also for the 8 mm PIFA (FIG. 3B ) and PIFA open irrigated catheters (FIG. 3C ), in comparison to their corresponding catheters (peak temperatures at 3 mm and 5 mm depths provided in Tables 1 and 2).
In addition, when measuring surface temperatures at distances of 1 mm, 2 mm, and 4 mm from each side of the PIFA ablation catheter, there were differences in mean tissue temperatures on each side of the 4 mm PIFA catheter (FIG. 4A-C ). Ablation on the insulated side of the PIFA catheter resulted in a lower temperatures at 1 mm, 2 mm, and 4 mm distances, compared to both surfaces of a standard 4 mm catheter, as well as the non-insulated side of the PIFA catheter. These findings were also similar for the 8 mm and irrigated PIFA. Table 4 provides the differentials between peak temperatures at 1 mm, 2 mm, and 4 mm distance from each side of the PIFA catheters, compared to their respective standard catheter. Shallow surface temperatures on the insulated side of the PIFA catheter were similarly low compared to those of a standard open irrigated catheter due to the unchanged open irrigation cooling effect (Table 4).
TABLE 4 |
Differential Surface Temperature Dispersion Between Insulated and Non- |
insulated Sides of PIFA Catheters, Compared to |
4 |
4 |
8 |
8 mm | P- | Irrigated | Irrigated | |||
PIFA | Standard | P-value | PIFA | Standard | Value | PIFA | Standard | P-Value | |
N | 16 | 25 | 16 | 16 | 16 | 16 | |||
Peak Differential | 6.7 ± 1.4 | 0.1 ± 0.9 | p < 0.001 | 3.7 ± 2.8 | 0.2 ± 2.1 | p < 0.001 | 2.5 ± 2.9 | 0.2 ± 2.9 | p = 0.031 |
|
|||||||||
mm (° C.) | |||||||||
Peak Differential | 1.2 ± 0.9 | 0.1 ± 0.8 | p < 0.001 | 2.2 ± 0.7 | 0.1 ± 0.7 | p < 0.001 | 1.6 ± 1.5 | 1.3 ± 1.8 | p = 0.612 |
|
|||||||||
mm (° C.) | |||||||||
Peak Differential | 0.03 ± 0.3 | 0.05 ± 0.5 | p = 0.455 | 0.5 ± 0.3 | 0.02 ± 0.4 | p = 0.002 | 0.9 ± 1.1 | 0.8 ± 1.4 | p = 0.890 |
|
|||||||||
mm (° C.) | |||||||||
There were no steam pops observed at 20 Watts during RF delivery for any the 3 PIFA catheters or their corresponding standard catheters. At 30 W, ablation using the 4 mm PIFA catheter resulted in a large percentage (75%, or 6 of 8 lesions) of steam pops. The incidence of steam pops was mitigated by using irrigated tip catheters as well as by using the larger surface area of the 8 mm catheter. At 30 W, ablation using the PIFA open irrigated catheter did result in steam pops but at a lower rate (28.5%, or 4/14); no steam pops were observed with the 8 mm PIFA catheter at 30 W or 60 W. There were no steam pops at 30 W for the standard catheters.
The steam pop rates were higher for PIFA catheters with a silicone-vinyl insulation, which has decreased thermal conductivity along with its electrical insulation. Hence, in addition to using a larger surface area and open irrigation to decrease the risks of steam pops, we also repeated the studies using an improved composite insulation with more thermal conductivity while maintaining electrical insulation. Using this composite of aluminum oxide and boron nitride, we did not have steam pops at 30 or 50 W for the PIFA 4 mm catheter. Furthermore, ablation at 30 W with an open irrigated PIFA using this composite insulation also did not result in any steam pops.
As a proof-of-concept experiment, three pigs underwent ablation using PIFA catheters. One of the potential side effects of epicardial ablation includes significant pericarditis, resulting from likely collateral ablation of the parietal pericardium. After epicardial access in three pigs, open irrigated PIFA ablation was performed. In the same 3 pigs, standard open irrigated control lesions were also performed in similar regions. Although the number of lesions was few (Table 5), there was a statistically significant difference in lesion sizes, 255.8 mm3 for PIFA lesions vs. 56.9 mm3 for control lesions, p=0.042. Furthermore, the pericardium adjacent to two control lesions demonstrated significant injury, compared to none for the PIFA lesions (FIG. 6 ).
TABLE 5 |
In vivo Epicardial Ablation of Porcine Model using PIFA Open Irrigation |
Catheter |
Standard | PIFA | ||
Open Irrigated | Open Irrigated | P value | |
Catheter | Catheter | (4 mm vs. | |
(N = 7) | (N = 6) | |
|
Maximum Depth | 3.7 ± 0.5 | 6.3 ± 2.5 | p = 0.021 |
(mm) | |||
Maximum | 6.7 ± 1.3 | 10.5 ± 2.6 | p = 0.007 |
Diameter (mm) | |||
Surface Diameter | 6.1 ± 1 | 9.1 ± 1.9 | p = 0.005 |
(mm) | |||
Volume (mm3) | 56.9 ± 24.2 | 255.8 ± 228.3 | p = 0.042 |
The partially insulated ablation catheters have been shown herein to exhibit significantly altered radiofrequency ablation properties. Specifically, in the examples, ablation of myocardial tissue with partially insulated catheters resulted in an increase in ablation lesion size beneath the non-insulated PIFA surfaces, while myocardial tissue on the insulated sides were protected and had only trivial evidence of ablation. The larger lesions created by the non-insulated sides of the PIFA catheters were associated with a larger reduction in electrical impedance and improved thermal conductivity below the non-insulated surfaces. Lesion sizes were insignificant and temperatures were lower for the insulated surfaces of PIFA catheters.
By insulating a portion of a standard ablation catheter, the effective current density on the remaining non-insulated metallic tip used for RF energy delivery is greatly increased, therefore leading to larger and, depending on catheter orientation, asymmetric lesions. Furthermore, in addition to having a smaller RF conductive surface area, there may also be an enhanced “edge effect” with partial insulation, due to the resultant semi-circular exposed metal of the modified ablation catheter. Besides the increased RF current density compared to standard non-insulated catheters, the non-irrigated PIFA catheters also demonstrated significant comparative reduction in RF heating of tissue along the insulated side. However, this reduction in heating on the insulated side was not significant for the open irrigated PIFA catheter. This may be due to the fact that the insulation decreased the saline flow through the catheter's bores on the insulated side, thereby preventing the full effects of saline irrigation on decreasing temperatures. Hence, although the insulation decreased temperatures, its effects were similar to, but not necessarily different than, open irrigation that is actively cooling that side of the catheter. An insulated open irrigation catheter that preserves the same degree of active cooling on the insulated side would exhibit a further decrease in tissue temperatures.
In 1995, Panescu and colleagues developed an altered tip geometry. Their device had an hour-glass shaped catheter ablation tip resulting in an increased regional current density. This was a forerunner of the 8 mm “peanut” ablation catheter. In addition to differences in the shape of an ablation catheter tip, the material used for RF conduction has also been explored. Recent investigations show increased RF heating with less electrode heating using gold ablation tips compared to standard platinum-iridium catheter tips. However, selective insulation of an ablation catheter tip has never been explored or suggested in the prior investigations seeking to improve tip performance.
Catheter ablation of cardiac tissue with radiofrequency (RF) energy is routinely performed for the treatment of a variety of arrhythmias. All radiofrequency ablation catheters are radially symmetric at the catheter tip cylinder, thus allowing for circumferential RF. However, there is an unmet need in catheter design that allows for a more tailored approach during RF ablation in which circumferential ablation is not desired. There are many circumstances where RF energy restricted to a single side of the catheter may prevent complications due to unintended collateral injury to vital structures adjacent to the targeted cardiac tissue. This situation is most commonly observed during RF application near the AV node, in the epicardium, and near the phrenic nerve. Furthermore, a circumferential catheter tip may lead to unintended loss of RF to surrounding blood flow, thus decreasing the efficacy of ablation. An insulated catheter, where RF energy is concentrated to a single side, will allow for a more effective ablation at lower powers, potentially improving safety. It will also permit RF delivery deeper into tissues and is therefore useful for difficult arrhythmias arising from deep structures such as the septum, papillary muscle, and cavo-tricuspid isthmus.
An insulated catheter has been designed and engineered, using a silicone-vinyl coating on half the surface of a catheter tip to direct RF energy preferentially and asymmetrically to the non-insulated side of the catheter tip. Ablation studies with these PIFA catheters have met two principal objectives for clinical applicability. First, it is shown herein that the insulated sides of the PIFA catheters have decreased temperature changes and minimal tissue injury when RF ablation is delivered. Secondly, it is shown that the non-insulated sides of these catheters deliver a greater degree of tissue heating with less power, which results in larger ablation lesions.
Ablation lesion dimension variations caused by external variables, such as circulation rate, passive catheter cooling, and catheter contact, were controlled by standardizing these variables upon repetitive energy delivery. Even after controlling for these variables, some variation remained in ablation lesion sizes noted with redundant energy delivery at different sites on the same section of excised myocardium, indicating uncontrolled confounding. This most likely represents local changes in ischemic myocardial tissue due to lack of perfusion, subtle changes in the angulation of the ablation catheter, and the immeasurable effect of passive cooling based on proximity to the circulating pump intake or output cannula. To reduce the impact of variable lesion size, energy delivery under similar conditions for each RF application was repeated and the mean ablation lesion size was applied when comparing the effects of partially insulated catheters. In addition, the variable conditions that may exist would be non-differential among the individual experiments.
Partially insulated ablation catheters resulted in increased lesion sizes from applied radiofrequency energy on the non-insulated surfaces of the catheters in an ex vivo model, due to increased RF current density. Partial insulation of an ablation catheter significantly altered the electrical properties at the tip-tissue interface of targeted myocardial tissue and resulted in the increased degree of RF heating. In addition, tissue adjacent to the insulated surfaces of the catheters had lower injury characteristics, with smaller ablation lesion sizes and lower temperatures.
The pore size can be tailored to address specific applications or needs. For example, larger pores will increase the exposure of the metal beneath the catheter insulation to the fluid in the area surrounding the ablation site. Thus, it is envisioned that pore sizes can vary from very fine perforations that are sparsely distributed over the surface of the insulated metal to large perforations that leave the surface of the metal largely exposed. The size of the gaps in the insulation can be important. For example, the spectrum of possible coating designs include ones like a fish net (very large “holes”) and ones like perforated leather (very small holes). The insulation on the tip of the catheter essentially interferes with contact between the tip and the tissue, but allows for contact with external blood/saline for controlled RF leaking or venting when utilizing a vented design such as is proposed, thus effectively diminishing the concentration of RF current at the tip-tissue interface in a controlled manner. This augments the safety of the catheter.
Partial insulation of an irrigated catheter tip with silicone and AOBN exhibited improved performance, and reduced tip temperature limitations, when compared to vinyl, vinyl-silicone, and polyurethane partial insulation. Significant differences in lesion volumes and temperature-limited powers were noted for control, silicone and AOBN tips (Tables 6 and 7). In addition, steam pops were significantly higher for silicone but not AOBN. AOBN created larger lesions, compared to controls.
TABLE 6 |
Myocardial Ablation Lesion Characteristics After Radiofrequency Energy |
Applied at 30 W (n = 10) for 60 Seconds Using Different Insulated Materials |
Average | Max | Impedance | |||||
Thermocool | Max Depth | Diameter | Surface | Steam | Volume | Drop | Peak temp |
Catheter | (mm) | Max (mm) | Diam (mm) | Pops | (mm3) | (Ohms) | (⊐) |
Standard | 2.9 ± 0.5 | 7.6 ± 0.7 | 6.1 ± 0.4 | 0/10 | 67.6 ± 17.1 | 6 ± 1 | 37 ± 1 |
(STD) | |||||||
Arctic | 4.3 ± 0.3 | 7.9 ± 0.9 | 6.8 ± 0.8 | 0/10 | 97.8 ± 23.7 | 25 ± 5 | 42 ± 2 |
Alumina | |||||||
(AA) | |||||||
Silicone (Sc) | 4.6 ± 0.4 | 8.6 ± 0.7 | 6.6 ± 0.3 | 1/14 | 130.7 ± 30.4 | 32 ± 8 | 41 ± 2 |
Vinyl | 4.1 ± 0.4 | 8.0 ± 0.8 | 6.2 ± 0.4 | 0/10 | 93.8 ± 24.8 | 19 ± 7 | 43 ± 1 |
Cyanoacrylate | 4.5 ± 0.4 | 8.4 ± 0.3 | 6.8 ± 0.2 | 1/14 | 115.0 ± 12.7 | 37 ± 6 | 42 ± 1 |
(Cy) | |||||||
Cyan | 5 ± 0.2 | 8.4 ± 0.6 | 6.4 ± 0.4 | 2/18 | 116.2 ± 18.2 | 44 ± 11 | 42 ± 2 |
w/graphite | |||||||
(Cy/g) | |||||||
Plastic (Pl) | 5.1 ± 0.3 | 8.9 ± 0.6 | 6.7 ± 0.5 | 1/21 | 146.1 ± 20.3 | 39 ± 10 | 39 ± 2 |
Marine | 4.6 ± 0.3 | 8.7 ± 0.9 | 6.9 ± 0.2 | 0/10 | 121.9 ± 26.8 | 26 ± 7 | 42 ± 2 |
Sealant (MS) | |||||||
AA vs. STD | p < 0.001 | p = 0.414 | p = 0.031 | p = 1 | p = 0.005 | p < 0.001 | p < 0.001 |
Sc vs. STD | p < 0.001 | p = 0.005 | p = 0.008 | p = 0.388 | p < 0.001 | p < 0.001 | p < 0.001 |
Vinyl vs. | p < 0.001 | p = 0.262 | p = 0.512 | p = 1 | p = 0.014 | p < 0.001 | p < 0.001 |
STD | |||||||
Cy vs. STD | p < 0.001 | p = 0.007 | p < 0.001 | p = 0.388 | p < 0.001 | p < 0.001 | p < 0.001 |
Cy/g vs. STD | p < 0.001 | p = 0.014 | p = 0.215 | p = 0.274 | p < 0.001 | p < 0.001 | p < 0.001 |
Pl vs. STD | p < 0.001 | p < 0.001 | p = 0.019 | p = 0.483 | p < 0.001 | p < 0.001 | p = 0.001 |
MS vs. STD | p < 0.001 | p = 0.006 | p < 0.001 | p = 1 | p < 0.001 | p < 0.001 | p < 0.001 |
TABLE 7 |
Myocardial Ablation Lesion Characteristics After Radiofrequency Energy |
Applied at 50 W (n = 10) for 60 Seconds Using Different Insulated Materials |
Average | Max | Impedance | |||||
Thermocool | Max Depth | Diameter | Surface | Steam | Volume | Drop | Peak temp |
Catheter | (mm) | Max (mm) | Diam (mm) | Pops | (mm3) | (Ohms) | (⊐) |
Standard | 4.7 ± 0.4 | 8.7 ± 0.6 | 7.1 ± 0.5 | 0/10 | 126.9 ± 29.1 | 15 ± 4 | 41 ± 1 |
Arctic Alumina | 6.1 ± 0.4 | 9.6 ± 0.6 | 7.5 ± 0.3 | 5/29 | 210.3 ± 28.7 | 30 ± 3 | 43 ± 1 |
silicone | Pop | 10/10 | |||||
Vinyl | 5.3 ± 0.3 | 9.6 ± 0.8 | 7.2 ± 0.4 | 0/10 | 173.6 ± 29.2 | 23 ± 5 | 45 ± 2 |
Cyanoacrylate | 5.6 ± 0.4 | 10.5 ± 1.1 | 8.3 ± 0.8 | 6/16 | 223.4 ± 52.9 | 36 ± 8 | 43 ± 2 |
Cyan w/graphite | Pop | 10/10 | |||||
Plastic | Pop | 10/10 | |||||
Marine Sealant | Pop | 10/10 | |||||
AA vs. STD | p < 0.001 | p = 0.003 | p = 0.059 | p = 0.160 | p < 0.001 | p < 0.001 | p < 0.001 |
Sc vs. STD | |||||||
Vinyl vs. STD | p < 0.001 | p = 0.010 | p = 0.653 | p = 1 | p = 0.002 | p < 0.001 | p < 0.001 |
Cy vs. STD | p < 0.001 | p < 0.001 | p = 0.001 | p = 0.027 | p < 0.001 | p < 0.001 | p = 0.009 |
Cy/g vs. STD | |||||||
Pl vs. STD p-value | |||||||
MS vs. STD p-value | |||||||
During a 30 second ablation at 50 Watts (power control mode), the mean temperatures recorded at 3 and 5 mm depths beneath the irrigated ablation catheter tip were significantly higher with ablation using an AOBN partial insulation, compared to a standard 4 mm catheter (FIG. 25 ). Further modification of the AOBN partial insulation with vents (FIG. 23 ) improved catheter tip-tissue interface temperatures, thereby overcoming any potential temperature limitations and allowing for equivalent lesion sizes. Vented AOBN achieved maximum 50 W powers (Tables 8 and 9).
TABLE 8 |
Myocardial Ablation Lesion Characteristics After Radiofrequency Energy |
Applied at 30 W (n = 20) for 60 Seconds using Arctic Alumina insulation and vented Arctic |
Alumina insulation |
Average | |||||||
Thermocool | Max Depth | Diameter | Max Surface | Steam | Volume | Impedance | Peak |
Catheter | (mm) | Max (mm) | Diam (mm) | Pops | (mm3) | Drop (Ohms) | temp (⊐) |
Standard (STD) | 3.1 ± 0.3 | 7.2 ± 0.6 | 5.8 ± 0.4 | 0 | 61.3 ± 10.5 | 6 ± 1 | 37 ± 1 |
Arctic Alumina | 4.7 ± 0.6 | 8.3 ± 1.2 | 7.0 ± 0.8 | 0 | 121.8 ± 43.3 | 26 ± 6 | 42 ± 2 |
(AA) | |||||||
Vented Arctic | 3.5 ± 0.2 | 7.4 ± 0.7 | 6.2 ± 0.5 | 0 | 74.2 ± 16.6 | 8 ± 2 | 40 ± 1 |
Alumina | |||||||
AA vs. STD | p < 0.001 | p = 0.001 | p < 0.001 | p = 1 | p< 0.001 | p < 0.001 | p < 0.001 |
Vented AA vs. STD | p < 0.001 | p = 0.561 | p = 0.003 | p = 1 | p = 0.006 | p < 0.001 | p < 0.001 |
Vented AA vs. AA | p < 0.001 | p = 0.005 | p = 0.002 | p = 1 | p < 0.001 | p < 0.001 | p = 0.001 |
TABLE 9 |
Myocardial Ablation Lesion Characteristics After Radiofrequency Energy |
Applied at 50 W (n = 20) for 60 Seconds using Arctic Alumina insulation and vented Arctic |
Alumina insulation |
Average | Diameter | Max | Impedance | ||||
Thermocool | Max Depth | Max | Surface | Steam | Volume | Drop | Peak |
Catheter | (mm) | (mm) | Diam (mm) | Pops | (mm3) | (Ohms) | temp (⊐) |
Standard (STD) | 4.4 ± 0.3 | 8.5 ± 0.5 | 6.8 ± 0.5 | 0/20 | 115.9 ± 17.2 | 11 ± 4 | 40 ± 1 |
Arctic Alumina | 6.2 ± 0.3 | 9.9 ± 0.7 | 7.8 ± 0.7 | 5/29 | 221.2 ± 32.7 | 33 ± 6 | 43 ± 1 |
(AA) | |||||||
Vented Arctic | 5.2 ± 0.2 | 9.5 ± 0.5 | 7.4 ± 0.5 | 1/29 | 167.0 ± 16.5 | 17 ± 3 | 42 ± 2 |
Alumina | |||||||
AA vs. STD | p < 0.001 | p < 0.001 | p < 0.001 | p = 0.033 | p < 0.001 | p < 0.001 | p < 0.001 |
Vented AA vs. STD | p < 0.001 | p < 0.001 | p < 0.001 | p = 0.358 | p < 0.001 | p < 0.001 | p < 0.001 |
Vented AA vs. AA | p < 0.001 | p = 0.032 | p = 0.028 | p = 0.085 | p < 0.001 | p < 0.001 | p = 0.002 |
An example of where the PIFA catheter can potentially improve safety is in the ablation of AVNRT, where ablation of the slow pathway is in the triangle between the tricuspid valve and the coronary sinus (FIG. 26 ), but the superior side of a standard ablation catheter applies unnecessary and unsafe RF towards the AV node. The insulated superior aspect of the PIFA mitigates this collateral damage to the AV node.
We have studied this particular application in porcine studies, where we ablated very close to the His cloud, as demonstrated by the dark ablation lesion tags next to the light His tags (FIG. 27 ). Ablation near the His region with an open irrigated PIFA catheter did not result in heart block (FIG. 28 ), n=0/6, compared to heart block occurring in all controls ablated with a non-modified irrigated catheter, n=6/6 (p=0.002).
Another application for PIFA is ablation near the phrenic nerve, both during atrial fibrillation and VT ablations. In these experiments, we alternate PIFA ablations, as denoted by light tags, with control ablations, denoted by dark lesion tags, for both endocardial and epicardial ablation near the right and left phrenic nerves (FIG. 29 ). We found that, in both epicardial and endocardial ablations, PIFA caused statistically significant fewer loss of phrenic nerve capture compared to controls (FIG. 30 ).
Radiofrequency ablation with partially insulated ablation catheters results in significantly altered tissue heating and lesion properties. Specifically, in the experiments presented herein, ablation of myocardial tissue with partially insulated catheters resulted in an increase in ablation lesion size and geometry beneath the non-insulated catheter tip surfaces, while myocardial tissue on the insulated sides were protected and had only minimal evidence of exposure to RF energy. The larger and asymmetric lesions created by the PIFA catheters were associated with a larger reduction in electrical impedance, which was likely due to an increase in the RF current density. Furthermore, the very thin coating of electrical insulation using a thermally conductive material resulted in insignificant tip temperatures given the same amount of power despite the lower amount of electrically active surface area compared to standard catheters using clinically relevant power settings.
By insulating a portion of a standard ablation catheter, the effective current density on the remaining non-insulated metallic tip used for RF energy delivery is greatly increased, therefore leading to larger and, depending on catheter orientation, asymmetric lesions. Furthermore, in addition to having a smaller RF conductive surface area, there may also be an enhanced “edge effect” with partial insulation, due to the resultant semi-circular exposed metal of the modified ablation catheter. Besides the increased RF current density compared to standard non-insulated catheters, the non-irrigated PIFA catheters also demonstrated significant comparative reduction in RF heating of tissue along the insulated side. However, this reduction in heating on the insulated side was not significant for the open irrigated PIFA catheter. This is likely due to the fact that the measured temperatures were at the surface of the myocardium, which would be affected by the unchanged cool saline irrigation fluid negating any effect of RF shielding at that shallow surface level. Hence, although the insulation decreased temperatures, its effects were similar to but not better than open irrigation that is actively cooling that side of the catheter at the very shallow tissue level. Analysis of the lesions created with this catheter, however, reveal tissue necrosis only inferior to the top border of the catheter, unlike non-insulated standard catheters. Because of this, structures immediately adjacent to this aspect of the catheter would be expected to be protected, as was observed in the in vivo porcine model using this catheter.
Catheter ablation of cardiac tissue with radiofrequency (RF) energy is routinely performed for the treatment of a variety of arrhythmias. All radiofrequency ablation catheters are radially symmetric at the catheter tip cylinder, thus allowing for circumferential RF. However, there is an unmet need in catheter design that allows for a more tailored approach during RF ablation in which circumferential ablation is not desired. There are many circumstances where RF energy restricted to a single side of the catheter may prevent complications due to unintended collateral injury to vital structures adjacent to the targeted cardiac tissue. This situation is most commonly observed during RF application near the AV node, in the epicardium, and near the phrenic nerve. Furthermore, a circumferential catheter tip may lead to unintended loss of RF to surrounding blood flow, thus decreasing the efficacy of ablation. An insulated catheter, where RF energy is concentrated to a single side, will allow for a more effective ablation at lower powers, potentially improving safety. It will also permit RF delivery deeper into tissues and is therefore useful for difficult arrhythmias arising from deep structures such as the septum, papillary muscle, and cavo-tricuspid isthmus.
An insulated catheter has been designed and engineered using a thin coating of thermally conductive material on half the surface of a catheter tip to direct RF energy preferentially and asymmetrically to the non-insulated side of the catheter tip. Ablation studies with these PIFA catheters have confirmed our two main hypotheses for its clinical applicability. First, we have shown that the insulated sides of the PIFA catheters have decreased temperature changes and minimal tissue injury when RF ablation is delivered. Secondly, we have shown that the non-insulated sides of these catheters deliver a greater degree of tissue heating with less power resulting in larger ablation lesions without the limitation of higher tip temperatures.
As used throughout the entire application, the terms “a” and “an” are used in the sense that they mean “at least one”, “at least a first”, “one or more” or “a plurality” of the referenced components or steps, unless the context clearly dictates otherwise. For example, the term “a cell” includes a plurality of cells, including mixtures thereof.
The term “and/or” whereever used herein includes the meaning of “and”, “or” and “all or any other combination of the elements connected by said term”.
The term “about” or “approximately” as used herein means within 20%, preferably within 10%, and more preferably within 5% of a given value or range.
Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the disclosure are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contain certain errors necessarily resulting from the standard deviation found in their respective testing measurements. Furthermore, when numerical ranges of varying scope are set forth herein, it is contemplated that any combination of these values inclusive of the recited values may be used.
As used herein, the term “comprising” is intended to mean that the products, compositions and methods include the referenced components or steps, but not excluding others. “Consisting essentially of” when used to define products, compositions and methods, shall mean excluding other components or steps of any essential significance. Thus, a composition consisting essentially of the recited components would not exclude trace contaminants and pharmaceutically acceptable carriers. “Consisting of” shall mean excluding more than trace elements of other components or steps.
The advantages set forth above, and those made apparent from the foregoing description, are efficiently attained. Since certain changes may be made in the above construction without departing from the scope of the invention, it is intended that all matters contained in the foregoing description or shown in the accompanying drawings shall be interpreted as illustrative and not in a limiting sense.
All references cited in the present application are incorporated in their entirety herein by reference to the extent not inconsistent herewith.
It will be seen that the advantages set forth above, and those made apparent from the foregoing description, are efficiently attained and since certain changes may be made in the above construction without departing from the scope of the invention, it is intended that all matters contained in the foregoing description or shown in the accompanying drawings shall be interpreted as illustrative and not in a limiting sense.
It is also to be understood that the following claims are intended to cover all of the generic and specific features of the invention herein described, and all statements of the scope of the invention which, as a matter of language, might be said to fall therebetween. Now that the invention has been described,
Claims (22)
1. An ablation catheter system for ablating tissue comprising:
a catheter body including a distal tip;
a circumferential ablation electrode at the distal tip of the catheter body; and
an insulating layer disposed over the circumferential ablation electrode and covering an arcuate section of a portion the circumferential electrode opposing an axis of energy emission from the circumferential electrode, the insulating layer having a plurality of openings passing there through that are configured to dissipate heat generated by the circumferential electrode away from target tissue to be ablated and reduce the dissipated heat applied to adjacent non-targeted tissue to non-ablative temperatures.
2. The ablation catheter system according to claim 1 wherein the distal tip of the ablation catheter is rotatable thereby facilitating an alteration in the orientation of the insulating layer.
3. The ablation catheter system according to claim 1 wherein the insulating layer is a thermally conductive electrical insulation.
4. The ablation catheter system according to claim 1 wherein the insulating layer is an aluminum oxide/boron nitride (AOBN) coating.
5. The ablation catheter system according to claim 1 wherein the insulating layer is selected from the group consisting of aluminum oxide, boron nitride, aluminum oxide and boron nitride composite, silicone, vinyl, polyurethane, carbon nanotubes oriented perpendicular to the RF current, graphite embedded in thermal epoxy and diamond embedded in thermal epoxy.
6. The ablation catheter system according to claim 1 wherein the circumferential ablation electrode is selected from the group consisting of a non-irrigated about 4 mm RF catheter tip, non-irrigated 8 mm RF catheter tip, and an open-irrigated RF ablation catheter tip.
7. The ablation catheter system according to claim 1 wherein the insulating layer covers about one-half of the catheter tip circumferential ablation electrode.
8. The ablation catheter system according to claim 1 further comprising one or more ports in the circumferential ablation electrode to allow for irrigation through the insulating layer.
9. The ablation catheter system according to claim 1 wherein the circumferential ablation electrode is elongate and has an inferior aspect and a superior aspect relative to the axis of elongation and the inferior aspect is adapted to contact tissue during ablation.
10. An ablation catheter system for ablating the tissue of a body comprising:
a catheter body including a distal tip;
a circumferential ablation electrode at the distal tip of the catheter body; and
an insulating layer disposed over an arcuate portion of the ablation electrode opposing the tissue to be ablated, wherein the insulating layer has a plurality of holes passing through the insulating layer and exposing portions of the ablation electrode through the plurality of holes in the insulating layer, and wherein the plurality of holes are configured to dissipate heat generated by the ablation electrode.
11. The ablation catheter system according to claim 10 wherein the insulating layer is a thermally conductive electrical insulation.
12. The ablation catheter system according to claim 10 wherein the insulating layer is an aluminum oxide/boron nitride (AOBN) coating.
13. The ablation catheter system according to claim 10 wherein the insulating layer is selected from the group consisting of aluminum oxide, boron nitride, aluminum oxide and boron nitride composite, silicone, vinyl, polyurethane, carbon nanotubes oriented perpendicular to the RF current, graphite embedded in thermal epoxy and diamond embedded in thermal epoxy.
14. An interchangeable ablation catheter tip for a radiofrequency ablation catheter comprising:
a circumferential ablation electrode, the ablation electrode comprising an insulating layer disposed over a portion of the ablation electrode that is opposite an axis of energy emission from the ablation electrode;
a plurality of vent openings passing through the insulating later and configured to dissipate heat generated by the ablation electrode away from targeted tissue and reduce the heat to sub-ablative temperatures; and
a connector, wherein the connector physically and electrically connects the interchangeable ablation catheter tip to a radiofrequency ablation catheter and the connector is adapted to releasably engage the interchangeable ablation catheter tip to the radiofrequency ablation catheter.
15. The interchangeable ablation catheter tip according to claim 14 wherein the circumferential ablation electrode is selected from the group consisting of a non-irrigated about 4 mm RF circumferential ablation electrode, non-irrigated 8 mm RF circumferential ablation electrode, and an open-irrigated RF circumferential ablation electrode.
16. The interchangeable circumferential ablation electrode according to claim 14 wherein the insulating layer covers about one-half of the circumferential ablation electrode.
17. The interchangeable circumferential ablation electrode according to claim 14 further comprising one or more ports in the insulating layer to allow for irrigation through the insulating layer.
18. The interchangeable circumferential ablation electrode according to claim 14 wherein the insulating layer has a plurality of holes dispersed over the insulating layer thereby exposing portions of the ablation electrode through the holes in the insulating layer.
19. The interchangeable circumferential ablation electrode according to claim 14 wherein the insulating layer is selected from the group consisting of aluminum oxide, boron nitride, aluminum oxide and boron nitride composite, silicone, vinyl, polyurethane, carbon nanotubes oriented perpendicular to the RF current, graphite embedded in thermal epoxy and diamond embedded in thermal epoxy.
20. The interchangeable ablation catheter tip according to claim 14 wherein the connector has threads that engage complementary threads on the radiofrequency ablation catheter.
21. An ablation catheter system comprising:
an elongated catheter body including a distal tip;
a plurality of interchangeable ablation catheter tips for a radiofrequency ablation catheter according to claim 14 , wherein at least two of the plurality of tips have a different electrode size, style, or pattern of insulating layer and wherein the connector of the interchangeable ablation catheter tip connects the interchangeable ablation catheter tip to the distal tip of the catheter body.
22. An ablation catheter system comprising:
an elongated catheter body including a distal tip;
a circumferential elongated ablation electrode having a length with a first end and a second end, wherein the first end is affixed to the distal tip of the catheter body and the second end extends away from the catheter body; and
an insulating layer disposed only over a portion of the circumferential elongated ablation electrode opposite from the tissue to be ablated, wherein the insulating layer further includes a plurality of openings passing through the insulating layer which are configured to dissipate heat to non-ablated tissues.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/942,442 US10806511B1 (en) | 2014-11-14 | 2015-11-16 | Partially insulated focused radiofrequency ablation catheter |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462079992P | 2014-11-14 | 2014-11-14 | |
US201562114371P | 2015-02-10 | 2015-02-10 | |
US14/942,442 US10806511B1 (en) | 2014-11-14 | 2015-11-16 | Partially insulated focused radiofrequency ablation catheter |
Publications (1)
Publication Number | Publication Date |
---|---|
US10806511B1 true US10806511B1 (en) | 2020-10-20 |
Family
ID=72838586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/942,442 Active 2038-07-18 US10806511B1 (en) | 2014-11-14 | 2015-11-16 | Partially insulated focused radiofrequency ablation catheter |
Country Status (1)
Country | Link |
---|---|
US (1) | US10806511B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4091565A1 (en) | 2021-05-18 | 2022-11-23 | Biosense Webster (Israel) Ltd | A catheter with multiple physically symmetrical ablation electrodes that are asymmetric electrically |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020049438A1 (en) * | 1999-10-05 | 2002-04-25 | Oratec Interventions, Inc. | Surgical instrument having distal face with first and second electrodes |
US20020120265A1 (en) * | 1999-12-23 | 2002-08-29 | Mayo Foundation For Medical Education And Research | Symmetric conization electrocautery device |
US20080091193A1 (en) * | 2005-05-16 | 2008-04-17 | James Kauphusman | Irrigated ablation catheter having magnetic tip for magnetic field control and guidance |
US20100174283A1 (en) * | 2009-01-05 | 2010-07-08 | Mcnall Iii Ralph I | Electrosurgical devices for tonsillectomy and adenoidectomy |
US20120303002A1 (en) * | 2011-05-27 | 2012-11-29 | Matthew Chowaniec | Method Of Internally Potting Or Sealing A Handheld Medical Device |
US20130090650A1 (en) * | 2011-10-11 | 2013-04-11 | Boston Scientific Scimed, Inc. | Renal nerve ablation cooling device and technique |
-
2015
- 2015-11-16 US US14/942,442 patent/US10806511B1/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020049438A1 (en) * | 1999-10-05 | 2002-04-25 | Oratec Interventions, Inc. | Surgical instrument having distal face with first and second electrodes |
US20020120265A1 (en) * | 1999-12-23 | 2002-08-29 | Mayo Foundation For Medical Education And Research | Symmetric conization electrocautery device |
US20080091193A1 (en) * | 2005-05-16 | 2008-04-17 | James Kauphusman | Irrigated ablation catheter having magnetic tip for magnetic field control and guidance |
US20100174283A1 (en) * | 2009-01-05 | 2010-07-08 | Mcnall Iii Ralph I | Electrosurgical devices for tonsillectomy and adenoidectomy |
US20120303002A1 (en) * | 2011-05-27 | 2012-11-29 | Matthew Chowaniec | Method Of Internally Potting Or Sealing A Handheld Medical Device |
US20130090650A1 (en) * | 2011-10-11 | 2013-04-11 | Boston Scientific Scimed, Inc. | Renal nerve ablation cooling device and technique |
Non-Patent Citations (8)
Title |
---|
Haines D., et al., Observations on Electrode-Tissue Interface Temperature and Effect on Electrical Impedance During Radiofrequency Ablation of Ventricular Myocardium. Biophysics of ablation: Application to technology. J Cardiovasc Electrophysiol 2004; 15:S2-S11. |
Haines DE, et al., Observations on electrode-tissue interface temperature and effect on electrical impedance during radiofrequency ablation of ventricular myocardium. Circulation. 1990;82:1034-1038. |
Hintringer F, et al., Prediction of atrioventricular block during radiofrequency ablation of the slow pathway of the atrioventricular node. Circulation. 1995;92:3490-3496. |
Killu Am, et al., Atypical Complications Encountered with Epicardial Electrophysiological Procedures. Heart Rhythm. 2013;10:1613-1621. |
Langberg JJ, et al., Radiofrequency Catheter Ablation; The Effect of Electrode Size on Lesion Volume In Vivo. Pacing Clin Electrophysiol. 1990;13:1242-1248. |
Nath S, et al., Basic Aspects of Radiofrequency Catheter Ablation. J Cardiovasc Electrophysiol. 1994;5:863-876. |
Otomo K, et al., Why a large tip electrode makes a deeper radiofrequency lesion: effects of increase in electrode cooling and electrode-tissue interface area. J Cardiovasc Electrophysiol. 1998;9:47-54. |
Yong Ji S, et al., Phrenic Nerve Injury: An Underrecognized and Potentially Preventable Complication of Pulmonary Vein Isolation Using a Wide-Area Circumferential Ablation Approach. J Cardiovasc Electrophysiol. 2013. |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4091565A1 (en) | 2021-05-18 | 2022-11-23 | Biosense Webster (Israel) Ltd | A catheter with multiple physically symmetrical ablation electrodes that are asymmetric electrically |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10709501B2 (en) | Catheter and method for improved ablation | |
US6290699B1 (en) | Ablation tool for forming lesions in body tissue | |
US7387629B2 (en) | Catheter design that facilitates positioning at tissue to be diagnosed or treated | |
US20050267467A1 (en) | Bipolar conforming electrode catheter and methods for ablation | |
AU2019280061B2 (en) | Irrigated electrodes with enhanced heat conduction | |
US20080161799A1 (en) | Position independent catheter | |
JP2010528804A (en) | Catheter for percutaneous transcatheter ablation of cardiac arrhythmia using bipolar radio frequency | |
Müssigbrodt et al. | Irrigated tip catheters for radiofrequency ablation in ventricular tachycardia | |
Nguyen et al. | Effects of radiofrequency energy delivered through partially insulated metallic catheter tips on myocardial tissue heating and ablation lesion characteristics | |
CA3104358A1 (en) | Ablation lesion device | |
US10806511B1 (en) | Partially insulated focused radiofrequency ablation catheter | |
Eick | Factors influencing lesion formation during radiofrequency catheter ablation | |
US10751122B2 (en) | Protective systems and methods for use during ablation procedures | |
US20210121229A1 (en) | Improved device for ablation | |
Nguyen et al. | Protection of critical structures during radiofrequency ablation of adjacent myocardial tissue using catheter tips partially insulated with thermally conductive material | |
McRury et al. | Efficacy of multiple ring and coil electrode radiofrequency ablation catheters for the creation of long linear lesions in the atria | |
Otsuka et al. | Characteristics of tissue temperature during ablation with THERMOCOOL SMARTTOUCH SF versus TactiCath versus QDOT MICRO catheters (Qmode and Qmode+): An in vivo porcine study | |
Monti et al. | Surgical Devices for Cardiac Radio-frequency Ablation | |
Hügl et al. | FIRST IN MAN BIPOLAR ROBOTIC MAGNETIC CASES: Feasibility and Safety in the Treatment of Patients with Ventricular Arrhythmia by Bipolar Irrigated Radiofrequency Ablation and Robotic Magnetic Navigation. | |
WO2001074442A1 (en) | Passively self-cooled electrode design for ablation catheters | |
US20050267462A1 (en) | Anchoring introducer sheath with distal slots for catheter delivery and translation | |
CA2553116A1 (en) | Anchoring introducer sheath with distal slots for catheter delivery and translation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |